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Abstract 
 
 
In neurons, microtubule motor driven transport is crucial for communication between processes 
and the cell body. Disruptions in transport are associated with a variety of neurodegenerative 
diseases. Recent studies implicate phosphorylation of serine 175, a conserved residue found in 
all three isoforms of kinesin-1 in impaired axonal transport associated with Huntington’s 
disease. Phosphorylation adds both negative charge and bulk to a protein. The mechanism by 
which S175 modification is related to impaired transport is not very well understood. It is not 
known whether phosphorylation of kinesin alone is sufficient to cause impaired cargo transport.  
To investigate the isolated effect of residue 175 on kinesin transport, we used optical trapping 
and single-molecule fluorescence imaging to study purified kinesin.  We found no significant 
difference in the processivity or ATPase activity of a phosphomimetic S175D construct or the 
non-phosphorylatable S175A construct. However, we did find that addition of a negative charge 
at S175 through phosphorylation or mutation led to a decreased stall force. Furthermore, 
polystyrene bead cargos coated with dynein and kinesin traveled preferentially in the minus 
direction when residue 175 of kinesin was negatively charged. These results show that 
modification of serine 175 alone is sufficient to alter the behavior of kinesin.  
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Chapter 1: Introduction and Background 
This chapter will introduce the study of a modification of one cytoskeletal motor, kinesin. This 
modification, called phosphorylation, involves the addition of a phosphate group in the kinesin 
motor domain and has been linked to neurodegenerative disease. Microtubule-based 
cytoskeletal motors and the biophysical techniques used to study these motors will be 
introduced.  
Section 1.1: Intracellular Transport 
The inside of a cell is a complex, crowded environment. To survive, a cell must ensure that all of 
the components within it exist at the right locations at the right time. For small cells, such as 
bacteria, the problem of moving intracellular components around is solved by simple diffusion. A 
typical protein inside a cell has a diffusion coefficient of 5-15 µm2/s  (1). The time to cross a cell 
can be solved from the relationship between the diffusion coefficient and mean-squared 
displacement in 3 dimensions: 
. 
For E. coli, which is approximately 1-2 µm long, this corresponds to approximately 10-100 ms 
for a protein to move across the cell (Figure 1.1A). This is fast enough for bacteria, which do 
rely on diffusion to move components from one location in the cell to another. In mammalian 
cells, which are much larger than bacteria, the time scales associated with using diffusion to 
move components to the correct positions become problematic. A typical mammalian cell is 
around 20 µm in diameter, which corresponds to 10 seconds for diffusion to move a protein from 
one end of the cell to the other, two to three orders of magnitude slower than in E. coli. While 
protein lifetimes vary from a few minutes to several weeks, diffusion in a typical mammalian cell 
would still be a viable transport mechanism for most proteins, but would not function well for 
both the shortest-lived proteins and large, membrane-enclosed organelles with much lower 
diffusion coefficients.  
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Figure 1.1: Size of different cell types. A. Bright-field image of E. coli cells. A typical E. coli bacterium is 2 µm long. B. 
Fluorescence image of a neuron with many processes that extend for hundreds of microns. Red is a mitochondria 
marker while green is fluorescent Homer1. The image of a neuron was recorded by En Cai.  
In neurons, the problem of transport becomes a concern (Figure 1.1B). A typical neuron is made 
of a central cell body from which many dendrites and a single axon extend (Figure 1.2). In 
humans, axons vary from 1 mm to 1m in length with the longest axon belonging to the sciatic 
nerve, which stretches from the base of the spine to each foot. It would take diffusion over 1,000 
years to move a protein from the base of the spine to the foot down the axon of the sciatic 
nerve.  
 
Transport in neurons and all other eukaryotic cells does not depend only on diffusion, as it is too 
slow and undirected. Eukaryotic cells contain a nucleus. Animals, plants, fungi and a number of 
unicellular organisms are all eukaryotes. In these cells, molecular motors carry cargo along 
cytoskeleton tracks within the cell. These are a set of proteins that bind cargo and walk along 
polymer filaments. The primary proteins involved in transport are the motors kinesin-1 and 
dynein. The filamentous tracks that the motors move on are made up of tubulin. These tracks 
extend down axons and dendrites in neurons and out from the nucleus in other eukaryotic cells. 
Tubulin units polymerize into microtubule tracks that have polarity. The “plus ends” of these 
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tracks are positioned at the tip of the axon, away from the cell body, while the “minus ends” are 
located closer to the cell body (Figure 1.2). Kinesin is responsible for plus end directed 
transport, while dynein moves toward the minus end.   
 
!
Figure 1.2: Microtubule motor transport in neurons. The axons of neurons are densely packed with microtubules with 
plus ends pointing toward the axon tip. Kinesin is a molecular motor that carries cargo toward the plus end of 
microtubules and dynein carries cargo toward the minus end.  
Many mechanisms are used by cells to regulate microtubule motor-based transport and direct 
cellular traffic (2). Cargo, tracks, and motors are modified to control the flow of traffic within the 
cell. Cargo attachment is regulated by a variety of scaffolding proteins that can specifically link 
cargo to a certain motor species (3). Microtubule tracks can be coated with tau and other 
microtubule-associated proteins (MAPs), which modify transport (4, 5). Both kinesin and dynein 
motors are also modified: for example, dynein is regulated by a large number of activator 
proteins that bind to it and modulate transport. Modification of kinesin-1 light chains, the parts of 
the protein that mediate attachment to cargo, is known to affect the association of cargo with the 
motor (6-9). 
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Every neuron has a single axon, which is a long, narrow process that extends off the cell body. 
The axon of one neuron contacts the dendrites of adjacent neurons at synapses. Neurons 
communicate through electrical and chemical signals that move across synapses.  Most protein 
synthesis in a neuron takes place in the cell body, so the ability of kinesin to move proteins and 
organelles down axons is crucial for the normal functioning of the nervous system. Defects in 
the regulation of axonal transport play an important role in a number of neurological disorders, 
including Alzheimer’s disease, Amyotrophic Lateral Sclerosis, Huntington’s disease, and Spinal 
and Bulbar Muscular Atrophy (SBMA) (10, 11).  
 
Section 1.2: Kinesin-1 Phosphorylation and Neurodegenerative Disease 
Studies have implicated the misregulation of kinesin in Huntington’s disease and SBMA, two 
incurable neurodegenerative disorders (12-16). In Huntington’s disease, neurons in the brain 
degenerate and die over time, leading to a loss of control of motion, personality changes, 
dementia, and death. The loss of brain matter associated with Huntington’s is illustrated in 
Figure 1.3. A 20-30% reduction in the volume of brain matter can occur (17). Huntington’s 
disease affects 5-10 out of every 100,000 people. 
 
Figure 1.3: A. Normal brain B. Huntington’s disease affected brain. Images from marcora.caltech.edu/science.htm.  
In SBMA, motor neurons in the brain stem and spine degenerate, resulting in progressive 
muscle weakness and atrophy. SBMA is an X-chromosome-linked disease that affects fewer 
than 1 in 150,000 males (females are not affected by SBMA) (18, 19). Both Huntington’s and 
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SBMA are genetic, trinucleotide-repeat diseases that are caused by excessive repetitions of the 
coding sequence for the amino acid glutamine (18-20). An expanded polyglutamine tract in the 
gene for huntingtin protein causes Huntington’s disease, while in SBMA, the disease is due to 
polyglutamine repetitions in the androgen receptor. Table 1 displays the relationship between 
the number of glutamine repetitions in these genes and disease pathology.  
DISEASE NUMBER OF 
GLUTAMINE 
REPETIONS 
EFFECT 
Huntington’s Less than 26 No disease 
 27-35 No disease, increased risk in offspring 
 36-39 Possible disease, later onset, reduced severity, 50% 
chance of passing disease to offspring 
 40+ Disease, 50% chance of passing disease to offspring 
SBMA Less than 34 No disease 
 35 No consensus as to whether there is a elevated risk of 
disease 
 36-37 Possible disease, but reduced severity 
 38+ Disease 
Table 1.1: The relationship between the number of glutamine repetitions and disease state for Huntington’s disease 
and SBMA (19, 20). 
Although it is well established that Huntington’s is a polyglutamine repeat disorder which occurs 
when more than 36-40 glutamine repetitions occur on the huntingtin protein, the function of 
huntingtin in the cell is poorly understood, but it is known to play some role in vesicle transport, 
endocytosis, cell signaling and apoptosis (21). In contrast, the role of the androgen receptor is 
better understood. It binds to DNA and regulates the expression of a variety of sex-linked 
genes. Despite their different roles, both mutant huntingtin and mutant androgen receptor are 
linked to a decrease in axonal transport via the activation of c-Jun N-terminal kinase-3 (referred 
to as JNK3), a stress-signaling protein that phosphorylates the motor domain of kinesin. The 
motor domain of kinesin is the region responsible for binding to microtubules and hydrolyzing 
ATP, kinesin’s energy source.   
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As a serine kinase, the role of JNK3 is to covalently attach a phosphate group to serine residues 
on other proteins (see Figure 1.4). It does this by reacting with its substrate, which is kinesin in 
this case, and a molecule of adenosine triphosphate (ATP), the energy currency of the cell. At 
neutral pH, the phosphate group has a charge of approximately -2e, while serine alone has no 
charge. Thus, the addition of a phosphate decreases a protein’s charge and also adds some 
bulk, slightly increasing the size of the phosphorylated serine. Phosphorylation by a kinase 
generally modifies the behavior of the substrate protein and is frequently used as a switch to 
turn proteins “on” or “off” as needed. Once activated by a cellular signal, a typical kinase will 
phosphorylate many different substrate proteins, amplifying the effect of the signal. The JNK 
family of kinases (which includes JNK1, JNK2, and JNK3) are stress signaling kinases that 
phosphorylate proteins in response to environmental cellular stressors such as UV radiation, 
heat shock and osmotic shock. Of these three, JNK1 and JNK2 are found throughout all 
mammalian body cells and JNK3 is specific to the nervous system (22). 
 
!
Figure 1.4: Phosphorylation of serine by a kinase. Serine is one of three amino acids that can be phosphorylated (the 
other two are tyrosine and threonine). A kinase is an enzyme that transfers a phosphate group from ATP to an amino 
acid residue, creating a phosphorylated protein and ADP.  At neutral pH, the phosphate group has a charge of -2e.  
Morfini et al. linked mutant huntingtin and mutant androgen receptor to an increase in activated 
JNK3 (13, 14). Using mass spectrometry, they discovered that JNK3 phosphorylates a serine 
that is found in all isoforms of kinesin-1 and is therefore said to be a “conserved” serine (14). In 
mammals, kinesin-1 occurs in three similar isoforms called “A”, “B”, and “C”. JNK3 specifically 
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phosphorylates serine 176 in the A and C isoforms and serine 175 in the B isoform. The 
numbering of amino acids is based on the convention that the first amino acid in a protein is 
located at the “N” terminus, or end of the protein with an exposed amino group. Under this 
convention, serine 175(176) is the 175th(176th) amino acid in kinesin.  
 
Morfini and Brady also established a link between addition of a negative charge at serine 175/6 
of kinesin and decreased axonal transport. They created a mutant form of kinesin in which the 
serine was replaced with a glutamine residue. Glutamine has a negative charge of 
approximately -1e at neutral pH and is slightly bulkier than serine. The negative charge and 
added bulk make it a common biological model used to mimic phosphorylation. In addition to the 
phosphomimetic mutation, a green fluorescent protein was attached to the kinesin for 
visualization in a fluorescence microscope. Upon expression of the mutant kinesin in rat 
neurons, less phosphomimetic kinesin was found in the axon tips than wild-type kinesin, 
suggesting a defect in the ability of the phosphomimetic kinesin to move along the microtubules 
in the axon.  
 
The Morfini, et al. studies did not suggest a mechanism for how addition of a negative charge 
could alter the behavior of kinesin. There are many unanswered questions regarding the 
mechanism by which JNK3 phosphorylation of kinesin leads to impaired transport. It is not 
known whether the addition of negative charge due to phosphorylation alone is sufficient to 
cause impaired cargo transport. It is also unknown what biochemical and biophysical properties 
of kinesin are modified as a result of S175/6 phosphorylation. To investigate the isolated effect 
of residue 175 on kinesin transport, we used optical trapping and single-molecule fluorescence 
imaging to probe the behavior of two kinesin mutants: a phosphomimetic construct S175D and a 
non-phosphorylatable construct S175A. We also used JNK3 to directly phosphorylate kinesin.  
We find that both phosphorylation and the S175D mutation attenuate the motor’s stall force and 
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bias cargo transport toward the minus end of microtubules. Thus, we conclude that 
phosphorylation alone is sufficient to alter the behavior of kinesin and thus affect transport. In 
order to develop an understanding of how phosphorylation could affect kinesin transport, the 
structure and function of the major players in microtubule transport must be first be considered. 
We therefore spend the rest of this section describing the key proteins involved in microtubule-
based motility and the techniques that permit the investigation of these proteins at both at the 
single-molecule level and in bulk assays.  
 
Section 1.3: Microtubules as Cellular Highways 
Microtubules are polymers that are part of the cytoskeleton. They provide structure to the cell, 
helping it to maintain its shape and also act as tracks along which motor proteins can carry 
cargo. They can be up to 25 µm long and are around 25 nm in diameter. They are hollow 
cylinders made up of protofilaments of tubulin dimers (Figure 1.5 A and B). Most microtubules 
inside a cell contain 13 protofilaments, but the number can vary from 8-19, depending on 
polymerization conditions (23, 24). The alpha and beta tubulin dimer is the basic unit from which 
protofilaments form. The end-to-end attachment of the tubulin dimers, with the fact that 
protofilaments form parallel to each other means that one end of the microtubule will have 
exposed alpha tubulin while beta tubulin will be exposed at the other end. This gives the 
microtubule polarity. The end with exposed alpha subunits is called the minus end and the end 
with exposed beta subunits is the plus end. Polymerization at the plus end is much more rapid 
than from the minus end. Inside a cell, most microtubules are oriented such that the minus ends 
are near the nucleus with the plus ends pointing radially outward. Transport from the center of 
the cell outward is called anterograde and transport from the membrane in toward the center of 
the cell is referred to as retrograde movement.  
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Figure 1.5: Microtubules. A. Tubulin monomers bind to form dimers. B. Dimers polymerize in protofilaments that form 
a hollow tube known as a microtubule. C. EM image and 3-D reconstruction of microtubules, from the Andreas 
Hoenger Lab at CU Boulder, http://hoengerlab.colorado.edu/docs/mm1.html.  
Section 1.4: Kinesin, a Strong, Plus End Motor 
The kinesin superfamily is a class of over 40 different proteins that hydrolyze ATP and move 
along microtubules. They are found in all eukaryotic cells. Most members of the family are plus 
end directed motors and play a role in transport or cellular division (25).  Kinesin-1, also called 
conventional kinesin, is the prototypical superfamily motor. It is responsible for the transport of 
diverse cargos such as vesicles, organelles, mRNA, and chromosomes.  
 
Kinesin-1 (referred to as “kinesin” hereafter for simplicity) is made up of two 120-130 kilodalton 
(kDa) heavy chains and two 60-70 kDa light chains as is shown in Figures 1.6 and 1.7. The light 
chains are not essential for motor function, but rather play a role in cargo-binding and motor 
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regulation. There are two different light chain isoforms, KLC1 and KLC2. Different types of cargo 
bind to different light chain isoforms, but the two light chain isoforms attached to the heavy 
chains are always identical (26). The heavy chains consist of three regions, an N-terminal motor 
domain, or “head”, a coiled-coil stalk and a C-terminal domain that associates with the light 
chains to bind cargo. The two heavy chains dimerize along the stalk region to form a motor with 
two motor domains and two C-terminal domains.  
!
Figure 1.6: Kinesin-1. The motor domains which bind to microtubules and hydrolyze ATP are shown in blue. The 
coiled-coil stalk is in grey, the cargo-binding domain is purple and the light chains are in green. The autoinhibitiory 
domain consists of residues within the C-terminal domain. From Vale, 2003 (27).  
 
Figure 1.7: Kinesin-1 domains according to residue number in isoform “B”. The motor domain is made up of residues 
1-328. The stalk consists of 329-914 and the C-terminal domain consists of 915-963.  From Marx, 2005 (28). 
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The motor domain binds to microtubules and hydrolyzes ATP, which provides the energy for 
kinesin to walk along the microtubule in a hand-over-hand manner. As it walks, kinesin moves 
along a single protofilament, taking 8 nm steps in a hand-over-hand style (29, 30). With every 
step, kinesin hydrolyzes a single molecule of ATP (31). Kinesin is a highly processive motor; it 
will take approximately 100 steps before dissociating from a microtubule. A single molecule will 
walk along a microtubule for ~1 µm before dissociating and several kinesin working together 
can have run lengths greater than 10 µm (32). Under conditions of saturating ATP, as is the 
case inside the cell, kinesin moves at a speed of ~1 µm/s. A single kinesin molecule is capable 
of exerting force up to 5-7 pN (33, 34). The maximum force kinesin can exert is called its “stall 
force”. Under no load, kinesin steps toward the plus end of the microtubule almost all of the 
time, taking backward steps toward the microtubule minus end less than 5% of the time (35). 
Under a load, backwards steps become more common, approaching the frequency of forward 
steps as the load applied to kinesin approaches its stall force (34, 35).  
 
Near the C terminus, kinesin has an autoinhibition domain (Figure 1.6). When not bound to 
cargo, kinesin adopts a folded configuration in which the autoinhibition domain docks at the 
motor domain (36, 37). In such a folded configuration, kinesin cannot hydrolyze ATP and has 
greatly reduced motility (38, 39). Cargo binding to kinesin relieves the autoinhibition, unfolding 
kinesin and restoring motility (38). Physiologically, autoinhibition is thought to prevent kinesin 
from unnecessarily hydrolyzing ATP when it is not needed for cargo transport.  
 
In mammals, there are three different isoforms of the kinesin heavy chain, labeled A, B, and C. 
The A and C isoforms are expressed only in neurons, but B is expressed in all cell types (40). 
Only recently differences in isoform function have begun to be investigated, but there is 
evidence that the transport of some types of intracellular cargo is isoform specific (41-43).  
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A conserved serine in all three isoforms, serine 176 in the A and C and serine 175 in the B 
isoform, can be phosphorylated by JNK3 (Figure 1.8). All experiments performed for this 
dissertation used the kinesin-1B isoform in which S175 is the relevant residue. S175 is located 
in the motor domain of kinesin, but does not fall in the ATP binding domain (residues 97-104) or 
the microtubule binding-domain (44, 45). However, computational and experimental studies of 
kinesin-microtubule interactions have traditionally focused on mutagenesis studies in which 
alanine is used to replace positive residues in the motor head, while the effect of adding an 
extra negative charge has not been investigated thoroughly (44, 45). 
!
Figure 1.8: Motor domain and location of S176. The motor domain of kinesin is shown in blue and green with serine 
176 highlighted in red. The figure was created by Yong Wang, using the PDB ID: 3KIN structure (46,47).  
Section 1.5: Dynein, a Minus End Motor 
Although dynein is the minus end directed counterpart to kinesin, it is a very different motor. In 
contrast to kinesin, which has been extensively studied and is well understood, there are many 
open questions about how mammalian dynein functions and is regulated. All three kinesin 
isoforms have been cloned and can be expressed heterologously and purified. This has 
permitted detailed studies of point mutations of kinesin and the attachment of fluorescent 
proteins and other tags; two developments that have been useful for tracking the motor. In 
contrast, mammalian dynein has not been successfully cloned purified in a non-native 
expression system (largely due to its large size), but instead must be purified from native tissue 
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and can therefore not be mutated or tagged with fluorescent proteins for tracking. Also, while 
there is a large superfamily of kinesin proteins, and different family members can exist as 
different isoforms, there are only two types of dynein. The first type, axonemal dynein, powers 
the beating motion of cilia and flagella, two microtubule rich structures, but does not play a role 
in transport. The second type, cytoplasmic dynein, is the only minus end directed microtubule 
motor that transports cargo in cells and will be referred to as “dynein” hereafter.  
 
Dynein is a large multi-subunit protein (Figure 1.9). It is 1.5 MDa in size, making it over 4 times 
as massive as kinesin.  Dynein consists of two 530 kDa heavy chains, six 50-75 kDa 
intermediate chains, and several light chains of approximately 10 kDa. The heavy chains are 
responsible for motility. Each contains one microtubule binding site and four ATP binding sites. 
Unlike kinesin, in which the ATP and microtubule binding sites are separated by only a few 
nanometers and the coupling of ATP to stepping is well understood, dynein’s ATP binding sites 
are located in a ring that is separated from the microtubule binding domain by a 15 nm long 
stalk. There are unanswered questions about how ATP binding in the rings is communicated 
down the stalk to the microtubule-binding domain. Studies in yeast and dictyostelium dynein 
suggest that ATP hydrolysis is coupled to stepping via sliding of the stalk coils, but the behavior 
of mammalian dynein has not been probed (48-50). The intermediate chains mediate cargo 
binding and the function of the light chains is poorly understood.  
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Figure 1.9: Dynein structure (combination of known structures and artist’s interpretation). The microtubule binding 
domains are shown in light blue, the ATPase domains are in blue and purple, and the intermediate and light chains 
are in green. From Vale (27). 
Like kinesin, dynein is a processive motor. Yeast dynein is very processive, with a run-length of 
approximately 1 µm. Mammalian dynein is slightly less processive with reported run lengths of 
300-900 nm (51-54). Unlike kinesin, which only takes 8 nm steps along a single protofilament, 
dynein is capable of stepping in multiples of 8 nm and can take off-axis steps across different 
protofilaments (51, 52). Furthermore, backwards stepping in which dynein moves toward the 
plus end of microtubules is observed even in the absence of a load (51, 55). This contrasts with 
kinesin, which only takes backward steps 5% of the time when no load is present, but will take 
more backward steps in response to an increasing load until, at a load equal to its stall force, 
kinesin takes equal numbers of backwards and forwards steps. Furthermore, kinesin walks 
strictly in a hand-over-hand manner in which the trailing head is always the head to step 
forward, but both the trailing and leading heads of dynein can take forward steps, suggesting 
that the ATPase activity of the two heavy chain monomers is uncoordinated (56, 57).  However, 
most of these studies were performed in yeast and there is evidence that there are fundamental 
differences in the behavior of mammalian and yeast dynein. Studies have consistently 
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measured a 7 pN stall force for yeast dynein, but the stall force of mammalian dynein is 
controversial (55). For mammalian dynein, most studies measure a 1 pN stall force, but some 
have measured 7 pN (53,58-60). Recent studies in two-motor transport (i.e., both kinesin and 
dynein) indicate that mammalian dynein interacts with the microtubule during motion toward the 
plus end, creating a drag force (60). Thus dynein is thought to “drag” behind kinesin. 
Mammalian dynein was used for the experiments in this dissertation.  
 
Section 1.6: Fluorescent Imaging with One-Nanometer Accuracy (FIONA) 
To track the motion of kinesin and dynein, sub-diffraction limited fluorescent imaging has been a 
valuable tool. With 8-nm step sizes, the nanometer is the relevant length scale for watching the 
motion of these molecules. FIONA (Fluorescence Imaging with One Nanometer Accuracy) is a 
very powerful technique that can be used to make such nanometer-scale measurements on 
motors. It was pioneered by Ahmet Yildiz in the Selvin lab. The first application of FIONA to a 
biological system was to measure the step size of the myosin V molecular motor with 1.5-nm 
precision in 2003 (61). Since then, FIONA has been applied to many other biological systems 
and has been very useful in tracking the diffusion of different species in the cytoplasm and cell 
membrane as well as in tracking motors (62). The premise behind FIONA is that one can 
measure the center of a point-spread function much more accurately than the diffraction limit of 
light, provided enough photons can be collected. To perform FIONA, single dye molecules are 
attached to the biological system of interest.  
 
The emission pattern of a fluorescent dye, known as a point-spread function (PSF), can be 
modeled as a two-dimensional Gaussian function. Although the physical form of a point-spread 
function from a point source is an Airy function, an analysis by Cheezum et al. discovered that 
the best fit to individual dye molecules is a Gaussian function (63). The distance from the central 
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maximum to the first minimum of the Airy disk of a point source of light, such as a single 
fluorescent dye is 
. 
 
For a 1.4 NA microscope objective and 500 nm light, this is approximately 250 nm. However, by 
localizing the centroid of the Gaussian with the precision given by the standard error of the 
mean, the position of the dye can be determined to within a few nanometers. This is illustrated 
in Figure 1.10. The diffraction-limited width of the pattern of emission of a single fluorophore is 
around 250 nm, but the center of the emission can be located with much greater precision than 
250 nm.  
 
!
Figure 1.10: Fluorescence from a single dye molecule. From Yildiz, et al. (61).  
The precision is governed by the number of photons emitted by the dye and by noise in the 
experimental apparatus, according to  
.  
Here N is the number of photons observed by the detector (a CCD camera for our experiments), 
s is the standard deviation of the Gaussian fit to the dye molecule fluorescence, a is the 
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effective size of the pixel, and b is the standard deviation of background counts observed by the 
detector. The first term under the square root describes the photon noise, the second term is 
due to the finite pixel size of the detector, and the final term is the noise of the background. For 
large numbers of photons, the limiting term is the photon noise. Our fluorescence imaging falls 
into this regime. Our apparatus has an effective pixel size of 106.7 nm and a background 
standard deviation of approximately 5 photons per pixel. For these settings if 10,000 photons 
are collected, the photon noise term is a factor of six larger than the background noise and a 
factor of 70 larger than the pixel noise term. 
 
In theory, the localization precision can be made arbitrarily small by collecting more photons at 
the detector. In practice, the precision is limited by the brightness and lifetime of organic dyes. 
After prolonged excitation with a laser, organic dyes will photobleach, undergoing irreversible 
chemical damage or covalent modification. This occurs primarily when a dye enters an excited 
triplet state in which it can react with chemicals in its environment. In order to be suitable for 
biological experiments, a dye must not only emit a sufficient number of photons but do so on a 
timescale appropriate for the measurement. The motility experiments performed for this 
dissertation used large (500 nm) fluorescent beads coated with many dyes and quantum dots, 
semiconductor nanocrystals that do not photobleach, so fluorescent lifetimes were not a 
concern as both of these probes remained very bright for the duration of all experiments.  
 
Section 1.7: Total Internal Reflection Microscopy 
The signal to background ratio must be very high for tracking single fluorescent particles. To 
achieve this, total internal reflection fluorescence microscopy (TIRF) is used. The TIRF 
technique was first used to study cell membranes by Daniel Axelrod in 1981 and used in vitro to 
study single myosin motors in 1995 by the Yanagida laboratory (64, 65). To accomplish TIRF, 
! ")!
the laser used to excite the fluorescent probes is angled such that it hits the glass-buffer 
interface at an angle greater than the critical angle for total internal reflection (Figure 1.11). 
  
Figure 1.11: TIRF microscopy: When laser light hits the glass-water interface at an angle greater than the critical 
angle, the laser will be reflected. An evanescent wave will illuminate a thin section (~100nm) near the surface of the 
coverslip.  
This creates an evanescent field that decays exponentially according to  
, 
where I0 is the incident intensity at the glass-buffer interface, z is the distance away from the 
interface and d is the penetration depth of the laser. The penetration depth, d, is given by  
. 
In this expression, ! is the wavelength of the incident light (in a vacuum), n1 is the index of 
refraction of the cover slip, n2 is the index of refraction of the buffer solution, and " is the angle 
of incidence. For the imaging conditions used in this work, TIRF microscopy was employed to 
create an evanescent field that penetrated the sample to a depth of approximately 100 nm. By 
only exciting the sample to a depth of 100 nm, we excited only the material close to the cover 
slip surface while excluding the volume above the surface, avoiding the background 
fluorescence of particles in solution far away from the cover slip surface.  
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Section 1.8: Optical Trapping 
The forces generated by cytoskeletal motors are on the order of a few piconewtons. Optical 
traps, which exert forces in the piconewton regime, are well suited for probing the force of single 
kinesin molecules. By attaching micron-sized cargo to a kinesin motor, it is possible to optically 
trap the cargo and measure the force the motor can exert.  
 
Optical traps use highly focused light to hold micron-sized particles in place. Arthur Ashkin and 
colleagues at Bell Laboratories developed the first optical trap in 1985, when they used focused 
light to trap polystyrene spheres (66). Since then, optical traps have been applied to a wide 
variety of systems, but have been particularly useful in measuring the biological forces of single 
molecules. In biology, optical traps have been used to measure forces associated with 
molecular motors, DNA, microtubules, and even entire cells (67-70).  
 
Objects from tens of nanometers to tens of micrometers in diameter can be trapped. To create 
an optical trap, a lens is used to bring a beam of light to a sharp focus. If a spherical object with 
an index of refraction that is higher than that of the surrounding media is brought in the vicinity 
of the focus, it will experience a force that tends to pull it towards the focus. The large range of 
utility of optical tweezers makes it difficult to give a single theoretical explanation of optical 
trapping. If the object to be trapped is much larger than the wavelength of light used for 
trapping, a geometric, or ray, optics approach is valid and can be used to calculate the trapping 
force on the object (71). However, if the object is much smaller than the wavelength of light, the 
particle can be modeled as a tiny induced dipole in an oscillating electric field. The trapping 
force then results from the interaction of the electric field with this dipole (72). The question of 
how to explain the trapping force becomes substantially more complicated if the particle is 
approximately equal in size to the wavelength of incident light. In this situation, neither the ray 
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optics nor the dipole approximation is valid, but a generalized Lorenz-Mie approach must be 
used (73).  
 
The trapping process in the ray optics regime is illustrated in Figure 1.12 for a sphere that is 
positioned slightly above the focus of the light rays, located where the orange lines cross in the 
figure. If the sphere has a greater index of refraction than the surrounding media, as is the case 
for polystyrene spheres in an aqueous buffer, which are commonly used to study motor 
proteins, the light rays will bend toward the normal as they enter the spheres. As the two light 
rays exit the sphere, they are bent away from the normal of the sphere according to Snell’s law. 
The net change in momentum of the light will be in the up direction, so the conservation of 
momentum dictates that the sphere will experience a change in momentum in downward, and 
hence move towards the focus. Similarly, if the sphere is placed slightly below the focus, the net 
change in momentum for the light will be in the downward direction, so the sphere will 
experience a force that tends to pull it up into the focus. 
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Figure 1.12: Illustration of the momentum change of focused light rays passing through a sphere. The refraction of 
the focused incident light rays is shown in purple and red while the dotted orange lines show the path the incident 
beams would take in the absence of the bead. The force diagram indicates that the net change in momentum of the 
light is upward, so the sphere will experience a downward force that will pull it to the focal point of the rays.  
A particle much smaller than the wavelength of the incident light can be modeled as a dipole. 
The expression for the force experienced by a small dipole, , in a non-constant electric 
field, , is 
  
! 
F = "
! 
E (
! 
r ,t) # $( )
! 
E (
! 
r ,t), 
where the dipole moment of the sphere is assumed to be linearly related to the electric field 
according to . The vector identity, 
, 
and the fact that the curl of an electric field is zero in electrostatics result in the simplification of 
the expression for the electric force on the dipole 
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. 
This force is directed towards where the electric field is strongest. If the trapping beam is 
Gaussian, the maximum electric field will be located at the focus and the particle will be trapped 
there. 
 
Although the third situation in which the particle is approximately the same size as the incident 
wavelength is the regime we operate in for most molecular motor experiments (using 1064 nm 
light and 500-1000 nm motor-coated beads), the derivation of the generalized Lorenz-Mie 
approach to solve for trapping forces is substantially more complicated than trapping in the ray 
optics or electric dipole regimes and is not given here. A good description of the theory in this 
regime can be found in Mazolli et al. (73).  
 
Section 1.9: Chemical Kinetics  
As it walks along the microtubule tracks, kinesin hydrolyzes one ATP molecule for every step it 
takes. The hydrolysis and stepping of the motor domains are highly coordinated, allowing for 
long processive runs in which kinesin takes 100 or more steps before dissociating from its 
microtubule track. A defect in kinesin’s ability to bind ATP or microtubules could impair kinesin 
and result in slower or less processive motion. Measuring the chemical kinetics of kinesin is one 
way to probe whether phosphorylation may affect kinesin’s motility by interfering with ATP or 
microtubule binding. This is done by determining the rate constants of ATP hydrolysis.  
 
Kinesin hydrolyzes ATP even in the absence of microtubules, but microtubules accelerate this 
process 1000-fold (74). In the presence of microtubules, kinesin’s ATP hydrolysis and stepping 
are coupled (75, 76). Figure 1.13 depicts the cycle of microtubule-enhanced ATP hydrolysis. In 
the top panel (A), kinesin is in a state with ATP bound to the trailing head, while the leading 
! #$!
head is nucleotide free. Kinesin will hydrolyze the ATP of the trailing head to ADP, which 
remains bound to the head, and phosphate, which is released into solution (panel B). An ADP-
bound head has a much lower affinity for microtubules than an ATP-bound head and will 
dissociate. The state shown in panel B is known as the “ATP waiting state”. In panel C, ATP 
binding to the leading head induces strain in the neck linker, which biases the rear head 
forward. Once the rear head releases ADP, it will bind to the microtubule in front of the original 
“leading head” (panel D) and the cycle can restart.   
!
Figure 1.13: Coordination of ATP hydrolysis and kinesin stepping. Figure used with permission (modified) from Yildiz, 
et al. (73). T indicates an ATP-bound head, D indicates an ADP-bound head, and # indicates a nucleotide-free head.  
The ATP hydrolysis of kinesin follows Michaelis-Menten kinetics (74, 77). Michaelis-Menten 
kinetics model the rate of an enzymatic reaction in which an enzyme, E, acts on a single 
substrate, S, converting it into a product, P, according to 
. 
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The rate constants in this process are commonly denoted as kon for the combination of the 
enzyme and substrate, koff for their separation and kcat for the formation of product. It is assumed 
that the formation of the product is irreversible, but that enzyme substrate formation is 
reversible. For ATP hydrolysis by the kinesin enzyme, these assumptions are true.  The 
hydrolysis of ATP into ADP and free phosphate releases 30.5 kJ/mol of energy, which makes 
the reverse process highly unfavorable. The rate equations for an enzymatic reaction are given 
by the law of mass action: 
. 
To derive the Michaelis-Menten result for the rate of product formation, it is assumed that the 
enzyme-substrate complex, ES, is at a constant concentration. In most systems, this 
assumption is correct. Shortly after the reaction begins, ES reaches a steady state and its 
concentration does not change appreciably until large amounts of the substrate, S, have been 
reacted. Assuming ES is at a steady state, equation 3 above becomes 
. 
The total enzyme concentration, [ET] is equal to the sum of the concentrations [E] and [ES], so  
.  
Solving for [ES], 
. 
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The rate of product formation is given by equation 4 of the rate equations. Substituting the 
above formula for [ES] into equation 4, yields  
. 
The maximum possible rate of product formation occurs when [ES]=[ET ] and is vmax=kcat[ET ]. 
Substituting this into the equation above and defining a Michaelis constant, Km=(koff+kcat/kon), 
produces the Michaelis-Menten equation for enzyme kinematics: 
. 
 
 
Figure 1.14: An example of a typical Michaelis-Menten curve. [S] is the substrate concentration in the reaction and v 
is the reaction rate.  
For the hydrolysis of ATP by kinesin, P is ADP, S is ATP, and E is kinesin. Every time it takes a 
step, one molecule of ADP is released, so the reaction rate will be directly proportional to the 
velocity of kinesin so v and vmax in the Michaelis-Menten equation can be expressed as 
! #'!
velocities in nm/s. Km is the concentration of substrate at which a reaction runs at half its 
maximum rate and measures the relative affinity of the enzyme for the substrate. The lower Km 
is, the higher the affinity between the enzyme and substrate.  For ATP hydrolysis, kinesin has a 
Km of approximately 50 µM. The microtubule dependence of kinesin’s ATPase activity also 
follows Michaelis-Menten kinetics, making it possible to define a KmMT that describes the 
relative affinity of kinesin for microtubules (78, 79). KmMT will vary according to the amount of 
kinesin and ATP used in the reactions to determine it and is therefore most useful as a 
comparative measurement.   
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Chapter 2: Materials and Methods 
This chapter describes the preparation of reagents, protocols, and data analysis procedures 
used in experiments.  
Section 2.1: Preparation of Motors and Their Tracks 
2.1.1 Buffers 
Various buffer solutions were used for the experiments. The formulations are listed below.  The 
pH of all buffers was adjusted using KOH. Sodium inhibits kinesin, so it was important that 
NaOH was avoided when adjusting pH. EGTA did not go into solution until around a pH of 6, so 
pHing buffers carefully was crucial to getting all components to dissolve. In the buffer solutions 
we used, either PIPES (piperazine-N,N!-bis(2-ethanesulfonic acid)) or HEPES (4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid)  was the a buffering agent. Both have pKa 
values (pKa = 7.5 for HEPES and pKa = 6.8 for PIPES) near the typical physiological pH of 7.3 
for mammalian cells, which made them useful buffering agents for biochemical reactions. EGTA 
(ethylene glycol tetraacetic acid) was used in all solutions to chelate calcium. Physiological 
concentrations of calcium are very low, and using EGTA to bind any calcium impurities in 
buffers mimicked the low physiological calcium levels and prevents unwanted interactions 
between calcium and the proteins in solution. Inside of cells, ATP is almost always found in 
complex with magnesium ions and Mg2+ is a required cofactor for many ATP hydrolysis 
reactions, including that of kinesin, so a magnesium salt was added to each buffer.  
 
BRB-80 
80mM PIPES 
1mM EGTA 
1mM MgCl2 
pH to 6.9 with KOH 
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Dynein Motility Buffer (DMB) 
30mM HEPES 
50mM KAcetate 
2mM MgAcetate 
1mM EGTA 
pH to 7.2 with KOH 
 
HEM 
50mM HEPES 
1mM EGTA 
2mM MgSO4 
pH to 7.2 with KOH 
 
2.1.2 Kinesin Constructs 
Experiments were performed using kinesin protein of three different lengths (Fig 2.1). The 
longest was full-length kinesin that contained all 963 residues in the heavy chain and was 
purified by Carol Bookwalter in the laboratory of Kathleen Trybus at the University of Vermont. 
The second-longest construct was truncated to remove residues after 888, keeping only the first 
888 residues of the kinesin heavy chain. Andrew Thompson in the Chris Berger laboratory at 
the University of Vermont purified this construct. An even shorter construct consisting of only 
residues 1-432 was purified by Marco Tjioe in the Selvin laboratory. Figure 2.1 illustrates the 
different kinesin constructs.  
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Figure 2.1: Illustration of kinesin constructs used in experiments. Adapted from (1).   
The full-length and Kinesin-888 (K888) constructs were purified as described in the literature 
(1).  Mouse kinesin-1B heavy chains and light chains were cloned into baculovirus vectors for 
expression in Sf9 cells. A hexahistidine tag was cloned to the N terminus of the heavy chain of 
the full-length heavy chain and a C-terminal biotin tag was added to the K888 heavy chains. 
Three different K888 heavy chain vectors were created. One in which the serine at residue 175 
was mutated to an alanine residue (S175A), one in which the serine was mutated to aspartic 
acid  (S175D) and one in which the original serine was left unmutated (WT). A C-terminal yellow 
fluorescent protein was added to the light chains. Sf9 cells were transfected with the baculovirus 
DNA coding for the heavy and light chains and recombinant baculovirus was purified. The 
recombinant virus was used to infect Sf9 cells and induce production of kinesin. Infected cells 
were lysed by sonication and centrifuged to separate the kinesin-enriched cytoplasm from other 
cell components. The supernatant of the centrifugation was applied to a His-Select nickel affinity 
column (Sigma-Aldrich) and washed with 30 mM imidazole to elute the his-tagged kinesin. The 
eluted kinesin fractions were concentrated and dialyzed against a buffer containing 10 mM 
HEPES, pH 7.3, 200 mM NaCl, 50% glycerol, 1 mM DTT, 10 µM MgATP and 1 µg/mL leupeptin 
and stored at -20 °C.  
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The truncated K432 was purified according to a protocol developed by Qiagen Inc. (2). A C-
terminal his tag and a biotin tag were added to a copy of the human kinesin heavy chain gene 
that had been truncated to contain the first 432 residues and the entire gene was inserted into a 
pET21a vector. BL-21 (DE3) E. coli cells were transfected with the vector and plated on Luria 
Broth (LB) agar with ampicillin for selection. A single colony from a plate was used to inoculate 
20 ml LB containing 100 µg/ml ampicillin and incubated at 37 °C overnight in a shaker at 200 
rpm. The next day the overnight culture was diluted 1:50 into 1 L of LB containing ampicillin and 
grown at 37 °C in a shaker at 300 rpm until an OD600 of 0.6 was reached. At OD600 of 0.6, 
expression was induced by adding isopropyl "-D-1-thiogalactopyranoside (IPTG) to a final 
concentration of 0.25 mM. The cells were grown for another 4-5 hours and then harvested by 
centrifugation at 4000 g for 20 minutes at 4 °C. The cell pellets were frozen and stored overnight 
at -80 °C. 
 
The next day, the pellets were thawed and purified using a Nickel-NTA resin (Qiagen, 30210) 
according to protocol 9 in the QiaExpressionist handbook (2). MgATP was added to all buffers 
to a final concentration of 40 µM. Eluted fractions enriched in protein were pooled and 10% 
sucrose was added as a cryoprotectant. Aliquots were flash frozen in liquid nitrogen and stored 
at -80 °C.  
 
2.1.3 Dynein 
Dynein protein was prepared by the laboratory of Trina Schroer at Johns Hopkins University (3). 
It was extracted from native bovine brain tissue. To summarize the protocol briefly, bovine 
brains were homogenized and centrifuged at 230,000 g to separate the cytoplasmic fraction, 
which contains dynein, from membranous components of the tissue.  The supernatant of the 
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centrifugation was flowed over an SP sepharose column (GE) to separate dynein from other 
cytoplasmic components based on charge (see section 2.2.3 for a discussion of ion exchange 
chromatography). The protein-enriched fractions from the SP sepharose column were then 
added to 20-60% sucrose gradients and centrifuged. In a sucrose gradient, proteins in the 
dynein-enriched fraction traveled through the gradient until they reached a point of equal density 
with the gradient. The centrifuged gradient was fractionated to separate the components in it 
based on density. Fractions enriched in dynein were run over a Mono Q column. (GE) The 
equilibration buffer consisted of 35 mM Tris, 5 mM MgSO4, pH 7.2 and KCl was added to elute 
the protein. After elution, 0.5 mM ATP and 1.0 mM DTT were added to dynein-enriched 
fractions. These factions were mixed in a 1:1 ratio with a buffer containing 2.5 M sucrose, 35 
mM Tris, 5 mM MgSO4, pH 7.2 and flash frozen for storage at -80 °C.  
 
2.1.4 Microtubules 
For fluorescence experiments, unmodified bovine brain tubulin (Cytoskeleton, HTS02), 
biotinylated porcine brain tubulin (Cytoskeleton, T333P) and fluorescent, HiLyte tubulin 
(Cytoskeleton, TL488M) were polymerized in a 25:5:1 ratio in BRB-80 containing 1 mM DTT, 1 
mM GTP, and 25% glycerol and a final tubulin concentration of 3.1 mg/ml.  For microtubule 
activated ATPase assay experiments, the biotinylated tubulin and fluorescent tubulin were 
omitted. The reagents were mixed on ice and then incubated at 37°C for 30 minutes to induce 
polymerization. After polymerization, the sample was diluted with a 4X volume of taxol solution 
consisting of room temperature 1 mM GTP and 20 #M taxol in BRB-80. Taxol binds to and 
stabilizes microtubules by inhibiting depolymerization. To remove unpolymerized tubulin 
monomers, the mixture was centrifuged at 15,000 g for 30 minutes at 24 °C. The supernatant 
was discarded and the pellet of tubulin polymers was gently resuspended in the desired 
concentration of taxol solution.  
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2.1.5 Axonemes 
Axonemes were prepared according to a protocol adapted from Gibbons and Fonk by Pierce 
and Vale (4, 5). Sea urchins were obtained from the Pt. Loma Marine Invertebrate Lab. Twenty 
sea urchins were ordered with the expectation that ten would be male. The protocol below was 
followed to obtain axonemes from the sea urchins.  
 
1. Inject live sea urchins (S. purpuratus) with a few ml of 0.5 M KCI. The exterior of the sea 
urchins is hard and cannot be penetrated with a syringe, except near the mouth opening. 
Set them on Styrofoam cups at 4°C so that semen or eggs will drip into the cup. Female 
sea urchins will produce orange-colored eggs. These are to be discarded. The white-
colored semen from male urchins should be collected.  
2. Collect the semen and dilute 3-fold with seawater (or Instant Ocean, sold at aquarium stores) 
at 20 °C. Rinsing remaining semen off the urchins may increase the yield. All solutions 
should be maintained at 4°C for this step and the remainder of the preparation.  
3. Centrifuge at 2000 g for 5 min to pellet sperm.  
4. Resuspend by douncing the pellet in the same volume of buffer 1 (5 mM imidazole : CI-, pH 
7.0, 100 mM NaCl, 4 mM MgSO4, 1 mM CaC12, 0.1 mM EDTA, 0.1 mM ATP, 7 mM 
BME) with 1% Triton X-100. Five or six passes of the douncing rod should be sufficient 
to resuspend the pellet in each step. Excessive douncing will shear the axonemes, 
resulting in shorter than desirable structures. Centrifuge at 1500g for 5 min to pellet 
sperm heads. Centrifuge the supernatant at 12,000g for 5 min.  
5. Repeat step 4.  
6. Resuspend the pellet by gently douncing in buffer 1. Centrifuge at 12,000g for 5 min. Repeat.  
7. Resuspend the pellet by gently douncing in buffer 2 (5 mM imidazole:Cl-, pH 7.0, 600 mM 
NaCI, 4 mM MgSO4, 1 mM CaCI2, 0.1 mM EDTA, 7 mM BME, 1 mM DTT). Incubate for 
10 min, then centrifuge at 12,000g for 5 min.  
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8. Repeat step 7, but add 1% Triton X-100 to buffer 2 and raise the pH to 8.0.  
9. Repeat step 6 with one additional resuspension and centrifugation (total of three spins).  
10. Resuspend pellet in one-fifth volume of buffer 1 containing 50% v/v glycerol. Store at -20 °C. 
Ideally, 20-30 mm long axonemes will be achieved. 
 
These steps produced a final volume of approximately 10 ml of axonemes at a concentration 
twenty or thirty times higher concentration than was used for experiments. The axonemes were 
stored in liquid nitrogen for long-term storage or at -20 °C for use within a year.  
 
Section 2.2: JNK3 Mediated Phosphorylation of Kinesin  
2.2.1 Phosphorylation  
To phosphorylate kinesin at S175, purified JNK3 enzyme was purchased from Millipore 
(JNK3/SAPK1b, 14-501). The concentrated enzyme was diluted to a concentration of 0.1 mg/ml 
in a buffer containing 50 mM Tris/HCl, pH 7.5, 150 mM NaCl, 0.1 mM EGTA, 270 mM sucrose 
and 0.1% 2-mercaptoethanol. Aliquots were flash frozen in 1ml volumes in liquid nitrogen and 
stored at -80 °C.  Phosphorylation was performed following a protocol based on that of Morfini 
(6). A basic reaction mixture is listed below which could be scaled up as necessary to produce 
more phosphorylated protein. We found that the activity of the kinase could differ significantly 
from lot to lot. The reaction as outlined here produced 80% phosphorylated protein with one lot 
of kinase, but only 30% phosphorylated with a different lot. The concentrations and volumes 
below was a good starting point, but amount of kinase that should be added to the reaction to 
produce good phosphorylation had to be optimized for each lot.  
 
1. On ice mix: 
 2 ml of approximately 20 µM kinesin 
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 1 ml of 7 mM ATP 
 0.5 ml of JNK-3 diluted to 0.1 mg/ml 
 3.5 ul HEM buffer 
 
2. Incubate the mixture at 37 °C for 30 minutes 
3. Add 50% sucrose in HEM to the mixture for a final concentration of 10%v/v  
4. Flash freeze and store at -80 °C 
 
2.2.2 Radiolabeling Assay to Quantify Phosphorylation 
To quantify phosphorylation, a radiolabeling assay was used. All radiolabeling assays were 
performed in the lab of Yi Lu at UIUC behind plexiglass shielding. In the Lu lab, reactions were 
run in collaboration with Seyed F. Torabi. Alongside the standard phosphorylation protocol 
outlined above, a second reaction was run which also contained 0.25 ml of [g-32P] ATP (Perkin-
Elmer) at a stock concentration of 1.67 mM. This ATP contains a radioactive phosphate at the 
g-position that JNK3 transfers to S175 of kinesin during the phosphorylation reaction. 
 
To measure the percentage of phosphorylated kinesin, an SDS-PAGE (Sodium dodecyl sulfate-
PolyAcrylamide Gel Electrophoresis) gel was run. SDS-PAGE was run by first mixing a protein 
sample with a loading buffer which contains SDS. SDS is a detergent that denatures protein and 
coats it with a negative charge (Figure 2.2 A). The SDS-protein mixture was loaded into a 
polyacrylamide gel matrix and an electric field was applied. Smaller proteins moved through the 
matrix faster, allowing different protein species in a mixture to be separated based on length 
(Figure 2.2 B).  
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Figure 2.2: SDS-PAGE. A. Native protein is denatured and coated with negative charges. B. Protein is run through a 
gel. Small proteins encounter less resistance as they move through the gel matrix and migrate farther into the gel 
than larger proteins.   
For the radiolabeling assay, the phosphorylation assay mix was run through a gel at 200 V for 
20 minutes to separate the kinesin from free, excess [g-32P] ATP and JNK-3. After this initial 
run, ATP standards were added to the gel. The standards were diluted such that the 100% 
standard would contain as much radioactive phosphate as kinesin that was 100% 
phosphorylated, the 50% standard would contain as much 32P as 50% phosphorylated kinesin, 
and so on. ATP migrates very quickly through the gel due to its small size in comparison to 
kinesin (kinesin heavy chains are 120 kDa, each, and ATP is only 0.5 kDa). To visualize ATP 
standards alongside the kinesin, the standards were added to the gel after the initial 20-minute 
run and allowed to enter the gel during a second run of 5 minutes at 200 V.  
 
The gel was exposed on a phosphorimager plate overnight and the resulting images were 
scanned. The intensity of the kinesin and ATP standard bands were measured and compared to 
determine the efficiency of phosphorylation.  
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2.2.3 Ion-Exchange Chromatography  
Although ultimately unsuccessful, as an alternative to radiolabeling, an attempt was made to 
separate phosphorylated from unphosphorylated kinesin using anion-exchange 
chromatography. Ion-exchange chromatography separates components in a mixture according 
to charge. In anion exchange chromatography, a sample is flowed through a column bed 
containing a positively charged resin. Negatively charged species will bind to the resin. A buffer 
gradient of increasing salt concentration in then flowed through the column and highly charged 
species will elute from the column at higher salt concentrations than species will less charge. 
Phosphorylation adds a charge of approximately -2e to a kinesin monomer in a solution at 
neutral pH. If successful, chromatography would have two advantages over radiolabeling. First, 
it does not involve the use of radioactive material and therefore avoids safety concerns 
associated with this. Second, if chromatography could separate the phosphorylated and 
unphosphorylated species, it would produce a sample with 100% phosphorylation. To be 
successful, differently charged species must elute from the column at distinct salt points, but 
only one broad elution peak of kinesin was ever observed for a variety of buffer and gradient 
conditions.  
 
Initially, an attempt was made to separate phosphorylated and unphosphorylated protein using 
a HiTrap Q HP 1ml column (GE, 17-1153-01). The column was equilibrated with HEM buffer 
containing 2 mM DTT and 0.1 mM ATP. The elution buffer was identical to that used for 
equilibration, but with the addition of 1 M KCl. JNK3 treated kinesin was added to the column 
and the unbound sample was washed out with 5ml of equilibration buffer. A linear gradient from 
0 to 1M KCl extending over 20 ml was applied at a flow rate of 3 ml/min. A single kinesin peak 
eluted at around 300 mM salt. The result of a single peak instead of a multiple peak indicated 
that the FPLC purification protocol was not sensitive enough to separate phosphorylated from 
unphosphorylated protein based on charge.  
! %#!
 
The protocol described above was iterated in an attempt to isolate phosphorylated protein. The 
attempted changes are listed below. None of the attempts led to a separation of phosphorylated 
and unphosphorylated protein.  
1.  HEM was replaced with BRB-80 to evaluate the effect of buffer conditions.  
2.  A shallower gradient from 0 to 500 mM over 20 ml was tested to evaluate whether multiple 
peaks would separate when the salt concentration was increased more gradually.  
3.  A Hi-Trap ANX-FF 1ml column (GE, 17-5162-01) was used in place of the Hi-Trap Q HP 
column to test whether a weaker anion exchange material would separate phosphorylated from 
unphosphorylated species.  
4. A Resource-Q 1ml column (GE, 17-1177-01) was used in place of the Hi-Trap Q HP column 
to test whether an anion exchange material with higher resolving power would separate 
phosphorylated from unphosphorylated protein. 
 
Section 2.3: Biochemical Assays 
2.3.1 Motor Concentration Measurement 
A Bradford assay was used to measure protein concentration. It is a colorimetric assay based 
on an absorbance shift in Coomassie Blue dye in acidic solution upon the addition of protein (7). 
In the absence of protein, Coomassie dye has an absorbance maximum at 365nm and is a 
reddish-brown color. Upon addition of protein, the absorbance maximum shifts to 595nm and 
the dye turns blue.  This shift is only observed in an acidic solution. Commercial formulations of 
the Bradford assay reagent contain a mixture of Coomassie dye and phosphoric acid.  
 
To measure protein concentration, 10 #l of a protein sample was diluted into 50 #l of Coomassie 
Plus (Bradford) Protein Assay (Thermo Scientific) solution in a glass test tube and left to 
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incubate at room temperature for 5 min. After 5 min, the mixture was transferred to a cuvette 
and the absorbance at 595 was measured using a UV/Vis spectrometer (BioRad). The protein 
concentration was measured by comparing the absorbance at 595nm to a standard curve of 
known concentrations of bovine serum albumin (Figure 2.3). The reactivity of the Bradford 
solution changes slowly over time, so a new standard curve was created monthly.  
 
!
Figure 2.3: Standard Bradford assay curve created using known concentrations of bovine serum albumin (BSA) 
protein.  
2.3.2 Single-Molecule ATPase Assay 
To measure the ATPase activity of kinesin, the velocity of quantum-dot labeled kinesin was 
measured at different ATP concentrations. The rate of ATP hydrolysis by kinesin follows 
Michaelis–Menten kinetics. At a given ATP concentration, [ATP], the velocity, v, of kinesin will 
follow  
 
. 
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Here, the maximum velocity at saturating levels of ATP is vmax and Km, the Michaelis constant, 
describes the affinity of kinesin for ATP.  
 
To measure velocity as a function of ATP concentration, axoneme tracks were first stuck to 
cover glass in a flow chamber and motors were allowed to walk on these. Flow chambers were 
prepared by attaching two pieces of double-sided tape to a glass slide with a separation of 
approximately 0.5 cm. A glass cover slip was placed on top of the tape and excess tape was 
trimmed away with a razor blade. This created a narrow capillary chamber with a volume of 10-
20 ml.  
!
Figure 2.4: Diagram of a flow-chamber 
Reagents were flowed into the chamber according to the following protocol. 
Axoneme Preparation 
1. Dilute axonemes 1:30 in BRB-80 buffer. Flow the dilution into the chamber. 
2. Incubate the axoneme-containing chamber for at least 20 minutes at 4°C. Wrap in foil to 
protect the chamber. 
3. Wash the chamber with DMB containing 8 mg/ml of BSA (DMB-BSA) and 1 mg/ml casein for 
blocking and incubate for 10 minutes at 4°C.  
Motor Preparation 
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1. While the axonemes are incubating, dilute kinesin to 0.8 #M in BRB-80 containing 10 mg/ml 
of BSA and 10 mM DTT 
2. Mix 0.5 µl of the diluted kinesin with 0.5 µl of 2 #M 655-streptavidin coated quantum dots 
(Invitrogen, Q10021MP) and incubate at 4°C for 30 minutes. 
3. Dilute the kinesin and quantum dot mixture 1:5 into 100 #M biotin in BRB-80 and incubate for 
10 minutes on ice. 
4. Prepare an imaging buffer. To a base of DMB-BSA, add 1 mg/ml PCA (3,4-Dihydroxybenzoic 
acid, Fluka, 37580), 100 nM PCD (Protocatechuate 3,4-Dioxygenase, Sigma, P8279), 2 
mM creatine phosphate, 5 U/ml creatine kinase, 10 mM DTT and varying ATP 
concentrations from 10 #M to 1 mM 
5. Dilute the quantum-dot kinesin mixture 1 to 100 into the imaging buffer and flow into the 
casein-blocked axoneme chamber from step 3 of the axoneme preparation. 
 
Images were recorded for no more than 15 minutes following the introduction of kinesin into the 
imaging buffer to ensure the optimal functioning of the creatine kinase-creatine phosphate ATP 
regeneration system.  Images were taken on inverted Olympus Ixon 70 microscope with a 100X 
1.45 numerical aperture objective (PlanApo 100X 1.45 NA $/0.17) plus an extra 1.5 X 
magnification sliding lens, for 150X total magnification. A 488 nm argon-ion (Melles Griot, 
60mW, 543-AP-01) was used to excite the quantum dots and an Andor iXon EM + (DV-897E-
CS0) CCD camera was used to record images. ATP concentrations over 100 #M were recorded 
with a 50 ms frame exposure and those at less than 100 µM were recorded at with 100 ms 
exposures.  
 
Individual, motile quantum dots were tracked using an IDL FIONA program and velocities were 
extracted using Matlab code. For each ATP concentration, the velocities of at least 40 quantum 
dots were averaged.  Km and vmax were extracted using enzkin, a nonlinear fitting program for 
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enzyme kinematics in Matlab (enzkin.m by Giuseppe Cardillo, 
http://www.mathworks.com/matlabcentral/fileexchange/26653) 
 
2.3.3 Microtubule Activated ATPase Assay 
A microtubule-activated ATPase assay was used to measure the affinity of kinesin for 
microtubules. For these experiments, microtubules consisting of native tubulin only were 
polymerized in BRB-80, as described previously.  Tubulin was freshly polymerized immediately 
prior to each microtubule-activated assay experiment. The concentration of microtubules was 
measured by recording the absorbance at 280 nm of microtubules diluted in 6 M guanidine 
hydrochloride. The 6 M guanidine hydrochloride breaks up the microtubules into tubulin 
monomers and denatures the tubulin. The extinction coefficient, e, of denatured tubulin at 280 
nm is 115,000 M-1cm-1. Beer’s law gives the relationship between the extinction coefficient, the 
tubulin concentration, c, the absorption path length, l, and the absorbance, A: 
. 
ATPase activity was assayed using an ATPase Kinetic ELIPA Assay Kit (Cytoskeleton, BK051). 
This enzyme linked assay works based on the protocol developed by Webb (8). Free inorganic 
phosphate is released when kinesin catalyzes ATP. The assay mix contains another enzyme, 
purine nucleotide phosphorylase (PNP), which catalyzes the reaction of 2-amino-6-mercapto-7-
methylpurine ribonucleoside (MESG) and inorganic phosphate into 2-amino-6-mercapto-7-
methyl purine. This conversion is accompanied by a shift in the absorbance from 330 nm to 360 
nm.  
 
The following protocol was repeated for each assay point.  
1. Mix fresh ELIPA assay buffer (EAB), consisting of 100 ml of the ELIPA reaction buffer with 20 
µM taxol, 24 µl Reagent 1 (MESG), and 1.2 ml of 100U/ml Reagent 2 (PNP).   
! %(!
2. Combine EAB with 50 nM kinesin, 0.5 mM ATP and vary the microtubule concentration 
between 0.1 and 8 mM microtubules, depending on the assay point. Add the ATP last as 
this starts the reaction.  
3. Immediately transfer the mixture to a cuvette and record the 360 nm absorbance at 3-second 
intervals for 5 minutes.  
 
It should be noted that MESG degrades quickly at room temperature and is only good for 
approximately 30 minutes after having been thawed, so these steps should be performed 
quickly. Also, the reaction begins as soon as the ATP is thawed, so it is important to minimize 
the delay between steps 2 and 3 as much as possible.  
 
To measure the rate of phosphate release, a straight line was fit to the initial, linear section of 
the rate of change of 360 nm absorption to form an ATPase activity curve for a given assay 
point. A standard phosphate curve was used to convert the absorbance into number of moles of 
inorganic phosphate released. This standard curve was created by adding known 
concentrations of a phosphate standard (KH2PO4) to EAB. To calculate the KmMT and vmaxMT, 
for microtubule activation, the ATPase activity in units of moles of phosphate hydrolyzed per 
kinesin head per second were plotted as a function of the microtubule concentration. The 
resulting data followed Michaelis-Menten kinetics, agreeing with results in the literature (9, 10).  
A non-linear Michaelis-Menten fit was performed using the same enzkin matlab code as was 
used for the single-molecule ATPase assay (enzkin.m by Giuseppe Cardillo, 
http://www.mathworks.com/matlabcentral/fileexchange/26653).  
 
Section 2.4: TIRF Motility Assay of Kinesin and Dynein 
2.4.1 Axoneme Purification of Kinesin   
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For an accurate comparison of two different kinesin protein samples, it was crucial that 
measurements of the two different samples had identical activity and concentration. Immediately 
prior to every fluorescence measurement an axonemal purification was performed. The 
purification removed two undesirably protein fractions. It eliminated both kinesin that did not 
bind to microtubules and kinesin that bound, but did not walk. The purification was performed by 
diluting 2 ml of concentrated kinesin stock (6-20 #M) in 30 ml BRB-80 containing 20 mM DTT. 
10 µl purified axonemes were added and 3 ml of 50 mM adenosine 5!-(",%-imido)triphosphate 
(AMP-PNP, Roche, 10102547001) were added to the mixture and it was allowed to incubate on 
ice for ten minutes. AMP-PNP is an ATP analog that is only slowly hydrolyzed by kinesin, 
effectively trapping it in a microtubule-bound state (Figure 2.5).  
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Figure 2.5: Chemical formulas of A. AMP-PNP and B. ATP. The red arrows indicate the position at which kinesin will 
cleave ATP.  The presence of a nitrogen at this position in AMP-PNP inhibits cleavage.  
The axonemes were then centrifuged at 14,000 rpm at 4°C for 30 minutes. The centrifugation 
pelleted motors that successfully bound to the axonemes and were trapped by AMP-PNP. Dead 
motors that never bound to the axonemes remained in the supernatant, which was discarded. 
The pellet was visible as a fine, almost transparent layer on the bottom of tube used for 
centrifugation.  
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To release the active motors, the pellet was resuspended in an excess of ATP. 40 µl BRB-80 
containing 20 mM DTT and 8 mM ATP was added to the tube containing the pellet and the 
mixture was gently pipetted up and down several times to break up the pellet. 8mM ATP was far 
in excess of what would be saturating for the amount of kinesin in the mixture. As a result the 
kinesin motors began to hydrolyze ATP and in the process, some dissociated from the 
axonemes. The mixture was incubated on ice for 10 minutes and then spun in the centrifuge a 
second time at 14,000 rpm at 4 °C for 30 minutes. Any dead, stuck motors that were unable to 
hydrolyze ATP remained attached to axonemes and were pelleted along with them. The 
supernatant contained only motors that successfully hydrolyzed ATP. The concentration of the 
supernatant was measured using a Bradford assay and the supernatant was then diluted to an 
appropriate concentration for subsequent steps.  
 
2.4.2. Attachment of Motors to Cargo 
Motors were non-specifically attached to carboxylated beads according to a protocol developed 
by Melinda Hoffman-Tonks. 500-nm red carboxylated microspheres (beads) were diluted 2:3 
into DMB containing 8mg/ml of BSA (DMB-BSA) and briefly sonicated in an ice bath to 
dissociate any large aggregates of beads. Kinesin and dynein were diluted to the desired 
concentrations and were mixed with the beads in a ratio of 1:1:1. For experiments involving the 
K888 mutants, dynein was added at a concentration of 500 nM and kinesin at 10 nM prior to 
incubation with beads and for experiments involving full-length kinesin, dynein was added at a 
concentration of 167 nM and kinesin was diluted to 32 nM. The bead and motor mixture was 
incubated at 4°C for 30 minutes prior to imaging.  
 
To measure the polarity of microtubules, a reference kinesin, K432 was used. This was coupled 
to a fluorescent antibody as cargo (Figure 2.6B). 1ul of 4.4 mM K432 with a C-terminal His tag 
was mixed with 1 ml of Alexa-647 labeled anti-his (Qiagen, 126244141). This mixture was 
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covered with foil to prevent photobleaching of the dye and incubated on ice for 30 minutes. 
Figure 2.6 depicts the motor-coated beads and labeled reference kinesin.  
!
Figure 2.6: A. Fluorescent bead sample. B. Reference K432 sample 
A flow chamber was prepared according to the following instructions. 
1. Dilute BSA-biotin to 1 mg/ml in BRB-80 and flow into the chamber. Incubate at room 
temperature for 5 minutes. This step both functionalizes the glass with biotin and 
provides a coating of BSA to minimize non-specific interactions between the motors and 
glass surface.  
2. Flush the chamber with BRB-80 to remove excess BSA-biotin.  
3. Dilute neutravidin to 0.5 mg/ml in BRB-80 and flow into the chamber. Neutravidin has four 
biotin-binding sites and is thus able to link biotinylated microtubules to the biotinylated 
glass chamber. The neutravidin solution was incubated for 5 minutes at room 
temperature.  
4. Flush excess, unbound neutravidin with BRB-80.  
5. Dilute biotinylated, fluorescent microtubules were diluted to a final tubulin concentration of 50-
100 nM in BRB-80 containing 20 #M taxol and flow into the chamber.  Incubate for ten 
minutes at room temperature. 
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6. Check the microtubules at a microscope to ensure that they are at an appropriate density of a 
few per field of view and are firmly bound to the glass surface.  
7. Flush the chamber with BRB-80 plus 20 #M taxol.  
8.  Prepare an imaging buffer consisting of DMB-BSA, 20 mM DTT, 4 mM ATP, 1 mg/ml PCA, 
100 nM PCD, and 20 #M taxol. 
10. Add the reference kinesin to the imaging buffer to a final concentration of 3 nM.  
11. Dilute the motor and bead mixture 1:50 into the imaging buffer.  
12. Briefly sonicate the mixture in a water bath sonicator chilled with ice to break up any clusters 
of beads. Dip the imaging buffer tube into the mixer for a 1-2 seconds and repeat 5 or 6 
times.  
13. Flow the imaging buffer with beads and reference kinesin into the flow chamber. An 
illustration of the inside of an experimental chamber is shown in figure 2.7.  
!
Figure 2.7: Illustration of the two-motor experiment inside a glass chamber. Biotin-neutravidin linkages stick 
microtubules to the glass surface. Reference kinesin move toward the plus-end of the microtubule. Beads coated with 
both kinesin and dynein can move in either direction.  
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2.4.3 Imaging 
Images were acquired on an inverted Olympus Ixon 70 microscope with a 100X 1.45 numerical 
aperture objective (PlanApo 100X 1.45 NA $/0.17) plus an extra 1.5X magnification sliding lens 
coupled to an Andor EM-CCD camera (DV-897E-CS0). A 488-nm argon-ion laser (Melles Griot, 
60mW, 543-AP-01),) was used to excite the HiLyte488 microtubules, a 532-nm diode laser 
(World Star Tech, 30 mW, model #TECGL-30) was used to excite the fluorescent beads and a 
633-nm HeNe laser (Coherent HeNe laser, 4mW, model #31-2041-000) was used for imaging 
the Alexa647 dye attached to the reference K432. In the microscope, optical filters were used to 
separate the laser lines from the sample fluorescence. A z488/532/633rpc (Chroma) triple 
bandpass dichroic mirror was used in combination with a z488/532/635m (Chroma) triple 
bandpass emission filter. For viewing the microtubules, an additional sliding filter (Chroma, 
HQ525/50M) was used to block the emission of the fluorescent beads, which was very broad. 
For each field of view, images with the three lasers were taken sequentially. A single image of 
the microtubules was taken, followed by a 50 second movie of the reference kinesin taken at a 
frame rate of 10 Hz. Each fluorescent bead movie was taken at 10 Hz for 2000 frames. For 
every field of view, no more than 4 fluorescent bead movies were recorded. No more than 90 
minutes was allowed to elapse while recording data from a sample.   
 
2.4.4 Data Analysis 
Data was analyzed using Matlab code based on that written by Melinda Tonks-Hoffman and the 
PolyParticleTracker code package. PolyParticleTracker is localization and tracking code written 
by Salman Rogers that is freely available online (11). The analysis of data begins with using the 
Tonks-Hoffman program to determine the polarity of the microtubules in a field of view. An 
example of a field of view containing several microtubules is shown in figure 2.8A. First, a mask 
covering regions of the field of view where microtubules were located was created (Figure 2.8B) 
and was blocked into a set of rectangles (Figure 2.8C). Then, a kymograph of the reference 
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kinesin movie was created for each rectangular region in the mask (Figure 2.8D). The program 
displays the kymograph and asked the user to input the polarity of each microtubule or discard 
the microtubule for further analysis if the polarity was unclear from the kymograph. The most 
common reason for an unclear kymograph was that the microtubule was located at the edge of 
the 488 nm laser excitation, but just outside of the 633 nm laser excitation and therefore no 
reference kinesin could be seen traversing the microtubule. Rarely, two microtubules with 
opposite polarities would intertwine and reference kinesin could be seen walking in two 
directions over the microtubule.  
 
 
 
!
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Figure 2.8: A. Image of fluorescent microtubules. B. Mask created by thresholding the microtubule image. C. 
Rectangularization of the mask in B. D. Kymograph. The fluorescence across a microtubule was plotted horizontally 
with time on the vertical axis. The positive slope of the reference kinesin on this microtubule indicates that the plus 
end must be on the right. Vertical lines in the kymograph occur when reference kinesin stick to microtubules but are 
not motile.  
Once microtubules have been located and the polarity was known, a particle location algorithm 
was used to detect moving beads. The fluorescence intensity of the movie was normalized by 
summing the total intensity of each pixel throughout the bead movie and dividing each pixel by 
this sum. The movie was also masked according to the microtubule image results. Thresholding 
was then applied to the masked, normalized image. Pixels that were brighter than two times the 
standard deviation of the background were marked. In the three dimensional array of the 
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imaging plane as a function of time, volumes were formed which consisted of continuous areas 
marked pixels. For our imaging system, a threshold of 1,500 cubed pixels was applied as a 
lower bound for volume regions containing spots. This lower bound was necessary to remove 
beads which briefly diffused near the microtubule, but did not move along it or single, bright 
pixels due to cosmic rays hitting the EM-CCD camera. The overlap between regions of high 
intensity and the microtubule mask was compared to match moving beads to microtubules. 
Moving beads were excised into smaller sub-arrays and the polarity of the corresponding 
microtubule was recorded.  
 
Each bead sub-array that could be matched to a microtubule was then tracked using both 
PolyParticleTracker and an Interactive Data Language (IDL) FIONA program. 
PolyParticleTracker was used to roughly track bead position and further crop the images of the 
beads. Tracking was necessary to allow closer cropping of spots. The rough cropped trace of 
the sub-array could have spatial dimensions of tens of pixels. For long traces, it was likely that a 
second bead would also be seen moving along the microtubule for part of the movie or diffuse 
into the array and the FIONA Gaussian fitting was not equipped to handle more than one bright 
spot in a field of view. To separate multiple beads, PolyParticleTracker computed the tracks of 
all beads in the sub-array. Once the tracks were known, a 13x13 pixel box, centered at the bead 
position was cropped for each frame around each bead. FIONA was applied to locate the bead 
with approximately 1 nm precision within each 13 by 13 box. The PolyParticleTracker algorithm 
did a good job of locating and linking images into tracks, its fit to the center of each bead was 
computed by fitting the fluorescent to a polynomial and was less accurate than the Gaussian 
fitting of FIONA. The FIONA results and track from PolyParticleTracker were then combined to 
produce a trace of the bead position as a function of time.  
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The resulting traces and cropped beads were checked by eye a final time. Occasionally, several 
beads would stick together in a large, bright cluster and move along a microtubule. These 
clusters were obvious from their intensity and size and were removed to create a dataset 
consisting of only single, motile beads. The net distance traveled and average velocities over 
the course of the trace of these beads were plotted. Also, for every bead, the direction and 
motion and number of reversals, if any, was recorded. A reversal was defined as a change in 
direction of the bead with at least 500 nm traveled on either side of reversal point.  
 
Section 2.5: Optical Trapping Experiments 
2.5.1 Optical Trap Construction 
The optical trap was custom built by Benjamin Blehm. All data acquired on the trap was taken in 
collaboration with Benjamin Blehm or Janet Sheung, who operated the trap during data 
acquisition. The trapping and detection of particles was accomplished by two different lasers, a 
1064-nm trapping laser (SpectraPhysics, Nd:YVO4, BL-106C) and a 845-nm detection laser 
(Lumics, LU0845M150-1G36F10A). A Nikon 60X 1.2 NA water immersion microscope objective 
inside of an inverted Nikon TE-2000-U microscope was used to image the beads in the trap and 
both the detection and trapping lasers were directed through this objective.  
 
The position of the trapping laser was controlled by an acousto-optic modulator (Gooch & 
Housego, 23080-3-1.06). An AOM precisely controls the deflection of the trap laser on short 
time scales (100 ns), making it well suited for controlling the position of the trap. It is made of a 
material like quartz or glass that is attached to a piezo-electric transducer. The piezo-electric 
transducer vibrates at radio frequencies, causing waves to propagate through the glass. The 
sound waves alter the index of refraction of the glass in a periodic manner, creating an effective 
diffraction grating with “slit” spacing that depends on the wavelength of the input RF signal. The 
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AOM is designed such that most of the incident light ends up in the first diffraction maxima. 
Varying the RF signal changes the effective slit spacing of the grating and is used to control the 
position of the beam.  
 
The position of the bead within the trap is detected by a quadrant photodiode (QPD) placed 
conjugate to the back focal plane of the objective. As the particle moves in the trap, it will scatter 
light at an angle relative to the laser. Angular changes in the focal plane of the particle become 
position changes in the back focal plane of the objective. The back focal plane of the objective is 
imaged onto the QPD. The quadrant photodiode consists of four diodes in a 2 by 2 
configuration. The voltage of each diode is proportional to the intensity of light that is incident on 
it. Subtracting the two rows of the QPD produces a voltage that is proportional to the position in 
one dimension and subtracting the columns produces a voltage proportional to the position in 
the other dimension (Figure 2.9). For an appropriately chosen laser power, the voltage and 
position are linearly related. To convert the signal in of the QPD into position, a volts to 
nanometer calibration was performed by oscillating the position of the trap at 100Hz and 
comparing the amplitude of motion of a trapped bead to the known amplitude of the trap 
oscillation as described by Tolic-Norrelykke, et al (12). The trap electronics were controlled 
using a field programmable gate array (FPGA) data acquisition card and custom Labview code 
written by Benjamin Blehm (National Instruments, PXI-7851R and Labview v8.5). !
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Figure 2.9: Diagram of a quadrant photodiode. The diode current is first converted to a voltage and amplified. By 
selectively subtracting and adding voltages, voltages proportional to the particle position relative to the center of the 
trap are obtained. From http://www2.bioch.ox.ac.uk/oubsu/ebjknight/q4d.html. 
The power spectrum method was used to measure trap stiffness. The equation of motion of a 
particle in the trap is given by the Langevin equation, 
! 
m˙ ˙ x + "˙ x(t) + kx(t) = F(t) , 
where m is the mass of the particle, $ = 6%&r is the viscous drag coefficient (Stokes’ drag) of the 
buffer on the particle, k is the trap stiffness. F(t) is the Brownian noise due to thermal 
fluctuations and will have a mean of zero and a constant power spectrum such that 
! 
F( f )
2
= 4"kBT . 
Here T is the temperature and kB is the Boltzmann constant. The mass of the bead is very 
small, so the inertial term from the Langevin equation can be neglected. Taking the Fourier 
transformation of the rest of the equation of motion, 
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("2#$fi + k)x( f ) = F( f ) . 
Setting fc=k/2%$, and taking the modulus of this equation yields, 
! 
x( f )
2
=
kBT
"( fc + f )
2
. 
This is a Lorentzian function with a corner frequency of fc. The stiffness of the trap, k, can be 
measured by fitting the power spectrum of a bead in the trap to a Lorentzian function and using 
fc=k/2%$. For convenience, in our study the volts to nanometers conversion factor and stiffness 
were measured simultaneously by oscillating the trap position at a known frequency. The 
oscillation gives the V-to-nm factor and the power spectrum, excluding the peak due to the 
driving oscillation gave the stiffness.  
 
2.5.2 Optical Trapping Assay 
Motors were non-specifically attached to carboxylated beads in a similar manner as used in 
fluorescence imaging experiments. 500 nm red carboxylated microspheres (beads) were diluted 
2:3 into DMB containing 8 mg/ml of BSA (DMB-BSA) and briefly sonicated in an ice bath to 
dissociate any large aggregates of beads and then mixed in a 1:1 ratio with diluted kinesin. 
Kinesin was diluted such that no more than 50% of the beads in a given sample were motile. 
This criteria of 50% comes from the assumption that the number of motors bound to a bead 
follows a Poisson distribution in which the probability of having n motors bound is given by 
, 
where l is a fitting parameter. If less than 50% of beads brought near an axoneme bind, then by 
setting P(0) > 0.5, one finds that l is no greater than 0.7. In this case, the probability of a bead 
having two or more motors attached to it is no more than 14%. If one further considers that two 
motors at opposite locations on the bead will not be able to both simultaneously engage with the 
microtubule, the probability of having two motors simultaneously pull on a cargo would be less 
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than 2% for a sample in which 50% of beads did not bind (13). By requiring that fewer than 50% 
of beads in a sample were motile ensures that no more than one motor be attached to a bead 
and the trapping measurements were reflective of single-molecule behavior and not the result of 
multiple motors pulling against the trap.  
  
In practice, we found that diluting kinesin to 5-10 nM before mixing it with beads would produce 
a sample where 30-50% of beads were motile. After incubating the beads and kinesin for 30 
minutes at 4 °C an imaging buffer was prepared containing DMB-BSA, 20 mM DTT, 4 mM ATP, 
1mg/ml PCA, and 100 nM PCD. The bead and kinesin mixture was diluted 1:1000 in the 
imaging buffer and flowed over an axoneme slide. The axoneme slide was prepared in the 
same manner as for the single-molecule ATPase assay. A complete description of its 
preparation can be found in the section describing these experiments.  
 
Trap data was acquired at room temperature with a data acquisition rate of 4000Hz. The trap 
stiffness was set by adjusting the trapping laser power such that the stall force of a motor 
corresponded to a position approximately 100 nm away from the center of the trap. This 
ensured that the motion of the motors would be confined to the region where force was a linear 
function of cargo position.  
 
2.5.3 Data Analysis 
Matlab software written by Benjamin Blehm was used to find motor stalls. The program converts 
the data from the QPD into motor force using both the volts-to-nanometers conversion factor 
and the trap stiffness determined during calibration. The force exerted on a bead by the motor is 
plotted as a function of time and the user is asked to manually identify regions where the motor 
stalls. For this analysis, stalls were defined as flat periods of less than 1 pN variation in force 
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which last for at least 0.5 seconds that are followed by a sharp drop back to the center of the 
trap. An illustration of the general shape of a stall is shown in figure 2.10. 
!
Figure 2.10: Illustration of a stall. As the motor engages and begins to walk on the microtubule, the restoring force of 
the trap that the motor must work against increases. When the motor can no longer pull against the trap, it stalls for a 
period of time, creating a flat region in the force vs. time curve. Once the motor detaches, the bead will drop back to 
the center of the trap.  
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Chapter 3: Results 
Section 3.1: S175 Modification Does Not Alter Kinesin’s Chemical Kinetics 
3.1.1: Summary of Experiments 
We measured the ATPase activity of kinesin-888 in two different contexts. First, we measured 
the rate of ATP hydrolysis of different S175 mutants. To accomplish this goal, we varied the 
ATP concentration, while keeping the other experimental parameters constant. By measuring 
kinesin’s velocity as a function of ATP concentration, we determined the Michaelis-Menten 
constant, Km, which is a measure of the affinity of an enzyme for its substrate, here, ATP.  We 
also measured the microtubule-activated ATPase activity of kinesin-888. In these experiments, 
the microtubule concentration was titrated and ATP and kinesin concentrations were kept 
constant. These second experiments measured the affinity of kinesin for microtubules since 
microtubules are required for kinesin to hydrolyze ATP effectively (1).  
 
For both sets of experiments, we chose to focus on different kinesin-888 mutants. To briefly 
review, these three mutants were a phosphomimetic kinesin construct, S175D, in which an 
aspartic acid residue mimicked the negative charge of phosphate, a non-phosphorylatable 
alanine mutant, S175A, and a truncated mutant with a wild-type sequence (unmutated kinesin-
888, which we will refer to as WT). All of these mutants were truncated to remove the auto-
inhibitory C-terminal domain of kinesin, residues 889-963. The truncated kinesin is constitutively 
active and incapable of folding into its autoinhibited conformation. This allowed us to study the 
effects of S175 modification on kinesin-ATP and kinesin-microtubule interactions without 
autoinhibition, which by itself may be affected by S175 modification. For example an increase in 
autoinhibition would interfere with kinesin’s ability to bind to microtubules and hydrolyze ATP 
and confound the results.   
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3.1.2 S175 Modification Has No Effect on Kinesin’s Affinity for ATP 
To test the effect of a negative charge at S175 on the ATPase activity of kinesin, we measured 
the velocity of quantum-dot labeled kinesin as a function of ATP concentration. Although there 
are many bulk assays that measure the level of free phosphate released in an enzymatic 
reaction, we chose to perform a single-molecule experiment. The weakness of bulk assays is 
that they can be biased by inactive kinesin in the solution. While small, there is always some 
fraction of protein in a purified batch that is not motile.  A bulk assay would average over these 
differences, confounding the effect of a lower maximum reaction velocity and a less active motor 
preparation. The benefit of a single molecule experiment is that it allows a direct comparison of 
the maximum velocities of different preparations of kinesin. In our single molecule assay, only 
active motors that bound to the microtubule-rich axoneme tracks and walked were measured.  
 
We used ATP concentrations between 10 #M and 1 mM and measured the mean velocity of 40 
to 70 kinesin molecules attached to fluorescent quantum dots for each ATP concentration. 
Representative histograms of velocities measured at defined ATP concentrations are shown in 
figure 3.1. 
 
 
Figure 3.1: Kinesin velocity distributions at A. 20 mM ATP and B. 600 mM ATP.  Both histograms were complied from 
data taken with the S175A mutant.  
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The respective velocity was plotted against ATP the concentration and data was subsequently 
fit with the Michaelis-Menten function, as shown in Figure 3.2. The extracted kinetic parameters, 
maximal velocity and Michaelis-Menten constant, of each mutant are summarized in table 3.1. 
If adding a negative charge at S175 were to decrease the affinity of kinesin for ATP, we would 
expect a higher Km for the S175D mutant we tested. We found that the S175D mutation did not 
significantly change the Km or the maximum velocity of kinesin, (see Table 3.1). This indicates 
that an additional negative charge at this position does not alter kinesin’s affinity for ATP. 
Additionally, we did not observe different parameters for the S175A mutation relative to wild-
type protein. 
KINESIN MODIFICATION KM (#M) VMAX (nm/s) 
S175A 44 ± 9 493 ± 24 
S175D 44 ± 10 494 ± 28 
None (wild type) 35 ± 8 484 ± 23 
!!
Table 3.1: Table 3.1: Summary of the ATPase kinetics of kinesin-888 mutants.  
 
Figure 3.2: ATPase activity of kinesin. There is no significant difference in the velocity of the three different kinesin 
mutants as a function of ATP concentration. The error bars are the standard error of the mean velocity at each ATP 
concentration.  
! ''!
3.1.3 S175 Modification Does Not Have a Significant Effect on Microtubule Affinity.  
Having found that kinesin’s affinity for ATP was not affected, we next focused on its affinity for 
microtubules. These experiments had to be performed in bulk, to allow the precise adjustment 
of the microtubule concentration. In this set of experiments, the microtubule concentration was 
varied, while ATP was used at saturating concentrations. An enzyme-linked phosphatase assay 
was used to measure the rate of free phosphate released from ATP at different microtubule 
concentrations. As described in detail in the materials and methods section Chapter 2). The 
released phosphate was reflected by an increase in solution absorbance at 360 nm. Figure 3.3A 
shows an example plot of the increase in absorbance as a function of time. As time increases, 
the kinesin hydrolyzes progressively more of the ATP in the solution until the absorbance 
reaches a plateau. To measure the ATPase activity of the kinesin prior to ATP depletion, a 
linear fit to the data points in the first 30 seconds was used (Figure 3.3B). !
 
Figure 3.3: Microtubule activated ATPase assay data: The data for S175A is shown in blue, the data for S175D is 
shown in red and the green data points are control runs in which no motor was added to the assay mixture. The 
control shows that the addition of motor does not affect A360. A. The absorbance at 360 nm increases over time as 
kinesin hydrolyzes ATP. B. The first 30 seconds can be fit to a line.  
The resulting slope of the linear fit performed using the first thirty seconds can be converted into 
the number of ATP molecules hydrolyzed per motor domain of kinesin per second with two 
pieces of additional knowledge: the known concentration of kinesin that was added to the 
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solution and a standard curve relating A360 to the amount of phosphate added to the reaction. In 
between 1 and 10 nanomoles phosphate, A360 and the amount of phosphate in the assay 
mixture are linearly related. A standard curve linking phosphate concentration to A360 was 
generated using defined concentrations of KH2PO4 , and is shown in Figure 3.4.. !
 
Figure 3.4: Phosphate standard curve. KH2PO4 ,  was added to the assay mixture to measure the increase in 
absorbance at 360 nm as a function of phosphate concentration  
The microtubule activated ATPase activity of kinesin can reasonably be described by Michaelis-
Menten kinetics (however, we note that strictly MM kinetics are only applicable for single 
substrate reactions, while kinesin has two “substrates” ATP and microtubules). It is difficult to 
directly compare the maximum reaction velocity of different types of kinesin due to differences in 
preparation. More useful, is the Michaelis constant, KmMT, which is independent of the 
concentration of active protein in the solution. Figure 3.5 shows the resulting microtubule-
activated ATPase curves and table 3.2 summarizes the kinetic parameters measured in the 
single-molecule and microtubule-activated ATPase experiments As previously discussed, 
mutations in kinesin that negatively affect microtubule binding, but don’t affect the overall rate of 
ATP hydrolysis are expected to result in increased KmMT values (2). Our results show that there 
is no significant difference in microtubule affinity regardless of the charge at S175 (see Table 
3.2). For each kinesin mutant, the assay was repeated for two or three data points to check the 
consistency of the results.  
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Table 3.2: Summary of the ATPase kinetics of kinesin-888 mutants"! 
!
 
Figure 3.5: Microtubule activated ATPase curves. A nonlinear Michaelis-Menten fit was applied to each data set.  
Section 3.2: The Processivity of Kinesin is Not Substantially Altered by 
Modification of Residue 175 
Processivity describes the length scale of molecular motor transport. It is a measure of the 
distance a motor travels before dissociated from a microtubule. Kinesin is a very processive 
motor. It can take over 100 steps along a microtubule before dissociating (3, 4). Processivity 
depends on the mechanical coupling of kinesin’s ATP hydrolysis and stepping of the two heads 
and the strength of the kinesin-microtubule interactions (4). To probe whether the S175D 
mutation would have an effect on processivity, we measured the run length of different kinesin 
mutants. We labeled kinesin with quantum dots and combined FIONA with tracking to measure 
KINESIN MODIFICATION KMMT (#M) VMAXMT (ATP molecules/kinesin monomer/s) 
S175A 0.65 ± 0.25 10.6 ± 1.4 
S175D 0.74 ± 0.22 10.8 ± 1.1 
None (wild type) 0.70 ± 0.26 11.3 ± 1.6 
!!
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the distance travelled by kinesin before falling off the microtubule. All experiments were 
performed at saturating levels of ATP. Andrew Thompson at the University of Vermont 
performed experiments on the S175A and S175D kinesin-888 mutants and analyzed the data to 
extract distances. We plotted this data in the Selvin lab and fit it to an exponential distribution to 
extract the characteristic run length of kinesin. We measured a run length of 1.06 ± 0.08 #m for 
S175A (N=117) and 0.89 ± 0.08 #m for S175D (N=91). The resulting distributions are shown in 
figure 3.6. We applied a Kolmogorov-Smirnov significance test and found that the S175A and 
S175D distributions did not differ significantly with p = 0.48. !
!
Figure 3.6: Processivity: Run length distributions for S175A and S175D.  
 
Section 3.3: Measuring Phosphorylation Efficiency.  
The kinetic studies involved genetically modified phosphomimetic kinesin only. However, for 
later studies, we wanted to look at true phosphorylation. To accomplish this we established an 
in vitro phosphorylation procedure to conduct experiments on physiologically relevant, S175 
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phosphorylated kinesin. We used JNK3 to phosphorylate full-length kinesin. A small reaction 
with radioactive ATP ([$-32P] ATP) was run alongside a non-radioactive reaction to quantify the 
extent of phosphorylation as described detail in the materials and methods section. An example 
denaturing polyacrylamide gel of radiolabeled protein is shown in figure 3.7A. The first lane (1) 
contains the phosphorylated kinesin, indicated by an asterisk (*) near the band. The fainter band 
beneath the phosphorylated kinesin (**) is JNK3, which is known to autophosphorylate (5). The 
large dark spot at the bottom of the gel is unreacted, radiolabeled ATP. The right lanes, 2 
through 6 (marked by the arrow) are different concentrations of [$-32P] ATP, diluted such that the 
amount of radioactive phosphate in each band would correspond to a defined radiolabeling 
efficiency of kinesin. The intensities above the background level of the standard ATP bands 
were summed and compared to the intensity of the kinesin band. As shown as the black linear 
fit to the data points figure 3.7B, the band intensity as a function of phosphorylation efficiency 
increased linearly. The intersection of the standards with the red line, which marks the intensity 
of the kinesin band, occurs at 81%, indicating that around 80% of the kinesin motor domains in 
the reaction were phosphorylated.  
 
!
! ("!
 
 
Figure 3.7: Measuring phosphorylation using radiolabeling. A. SDS-PAGE of radiolabeled kinesin-1.  Lane 1 contains 
kinesin (*) and JNK3 (**) and unreacted [$-32P] ATP (large dark spot at the bottom left). Lanes 2 through 6 contain 
ATP standards corresponding to labeling efficiencies varying from 6 to 100% (arrow). Lane 6 contained to the amount 
of radioactive ATP that would correspond to 100% phosphorylation of kinesin, lane 5 to 50%, 4 to 25%, 3 to 12.5% 
and 2 to 6.25%. B. ATP standard band intensity as a function of P32 labeling of kinesin (black line) and kinesin band 
intensity (red line).  
Section 3.4: Phosphorylated and Phosphomimetic Kinesin Have a Reduced Stall 
Force 
We used optical trapping to measure the stall force of kinesin attached to 500 nm diameter 
polystyrene beads. For both phosphomimetic and phosphorylated kinesin, we observed a 
decrease in stall force relative to wild-type or non-phosphorylatable kinesin. We measured both 
types of different kinesin-888 mutants as well as full-length NK3 phosphorylated kinesin. The 
phosphomimetic S175D stalled at 5.28 ± 0.09 pN, while the non-phosphorylatable S175A 
mutant stalled at approximately 7.46 ± 0.25 pN (errors are given as standard error of the mean). 
Figure 3.8A shows a histogram of stall forces. Previous measurements have reported kinesin 
stall forces of 5-7 pN for unmutated protein (6, 7). Figure 3.8B shows a representative stall.  
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We also measured the stall force of JNK3 phosphorylated protein and found a decreased stall 
force. Wild-type kinesin-888 had a stall force of 7.44 ± 0.18 pN similar to the non-
phosphorylatable S175A mutant. 60% phosphorylation of wild-type kinesin-888 was achieved. 
As no complete phosphorylation was achieved there are potentially three populations of kinesin 
present in the sample: unphosphorylated kinesin as well as single and double phosphorylated 
motors. Assuming that the two motor domains are phosphorylated independently, 60% 
phosphorylation of motor head monomers would imply that 36% of kinesin dimers had two 
phosphorylated heads, 48% had one phosphorylated head and 16% had no phosphate present 
in either head. While it is difficult to assign a characteristic stall force to a heterogeneous 
sample, the mean stall force of this partially phosphorylated sample was 6.80 ± 0.17 pN, a 
decrease of 0.64 pN from the stall force of unmodified kinesin-888. Figure 3.8C shows the stall 
force histograms for this data.  
!
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Figure 3.8. Stall force data. A. Kinesin-888 stalls for the S175A (N=73) and S175D (249) mutants. B. A characteristic 
stall. C. Stalls force of unphosphorylated wild type kinesin-888 (N=68) and 60% phosphorylated protein (N=123). D. 
Stall force of unphosphorylated full-length kinesin (N=271) and 80% phosphorylated protein (N=440).  
A decreased stall force was also observed in phosphorylated wild-type, full-length kinesin. 
Unphosphorylated full-length kinesin had a stall force of 6.43 ± 0.10 pN. An 80% 
phosphorylated sample (assumed to consist of 64% dimers with two phosphorylated heads, 
32% dimer with one phosphorylated head and 4% with no phosphorylation) had a mean stall 
force of 5.54 ± 0.10 pN. Figure 3.8D shows stall force histograms for full-length kinesin. Table 
3.3 summarizes all stall force measurements. 
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KINESIN MODIFICATION KINESIN LENGTH STALL FORCE (pN) 
S175A 888 7.46 ± 0.25 
S175D 888 5.28 ± 0.09 
None (wild type) 888 7.44 ± 0.18 
60% phosphorylated 888 6.80 ± 0.17  
None (wild type) 963 (Full) 6.43 ± 0.10  
80% phosphorylated 963 (Full) 5.54 ± 0.10 
!
Table 3.3: Summary of stall force measurements. 
Section 3.5: S175 Modification Biases Transport Toward Microtubule Minus Ends 
To study to effect of kinesin phosphorylation in a more physiological context, we coated 
polystyrene bead cargo with both kinesin and dynein.!We attached kinesin and cytoplasmic 
dynein to 500 nm fluorescent polystyrene beads and observed the resulting motion. An example 
trace of bead position as a function of time is shown in figure 3.9. !
!
Figure 3.9: Example of a bead coated with full-length unphosphorylated kinesin and dynein undergoing bidirectional 
motion. FIONA was used to determine the position of the bead in each frame. Motion with a positive slope is directed 
towards the microtubule plus end and motion with a negative slope is directed toward the minus end.  
We characterized the motion of the two-motor coated beads with several measurements. We 
first measured the direction of the bead along a microtubule, counting how frequently beads 
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moved toward the plus-end, the minus-end, or reversed directions. We also measured the total 
distance traveled by a bead along the microtubule from the time it first contacted the 
microtubule to when it finally released from its track and diffused away. We also measured the 
average velocity of a bead during its transit.  
 
In our measurements of the direction traveled by beads, we looked at the motion of a reference 
kinesin that was labeled with a fluorescent antibody to determine the plus-end of the 
microtubule as described in chapter 2. We then monitored the direction of motion of beads 
coated with kinesin and dynein. We measured whether a bead moved only toward the plus-end, 
only toward the minus-end or underwent bidirectional motion. A trace was scored as displaying 
bidirectional motion if the bead was transported at least 500 nm in each direction both before 
and after a reversal. We found that beads coated with the phosphomimetic S175D kinesin 
mutant and dynein were showed decreased plus-end motility relative to beads coated with 
dynein and either wild-type kinesin or the S175A, alanine mutant. Figure 3.10A shows the 
results of our observation for the kinesin-888 mutants. Experiments using the JNK-3 treated, 
80% phosphorylated kinesin also showed a bias away from plus-end transport and toward 
minus-end directed transport linked to phosphorylation (Figure 3.10B).  
 
In order to control for the possibility that different protein preparations may have different 
amounts of active and inactive protein, we used the same dynein preparation for all experiments 
and performed an axoneme activity purification assay on the kinesin, as described in detail in 
the materials and methods chapter. The activity purification assay removed inactive proteins, 
leaving a sample consisting of active kinesin. The concentrations of dynein and kinesin were 
kept constant within the set of kinesin-888 experiments and the set of full-length experiments. !
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Figure 3.10: Direction traveled A. Cargo coated with S175A and dynein (red, N=110) or S175D and dynein (blue, 
N=195), and wild-type and dynein (green, N=72). (B) Cargo coated with full-length unphosphorylated kinesin and 
dynein (green, N=113), and full-length 80% phosphorylated kinesin and dynein (yellow, N=127). 
We also measured the total distance traveled by beads carried by two different motors. We set 
the origin to be the location where the bead first contacted the microtubule. Positive distances 
corresponded to motion toward the plus-end and negative distances corresponded to motion 
toward the minus-end. On average, phosphomimetic kinesin (S175D) and dynein-coated cargo 
showed motion shifted toward the minus-end relative to motion of cargo coated with S175A and 
dynein. Table 3.3 summarizes the mean velocities and distances traveled and figure 3.11 shows 
the distributions of velocities and distances traveled for each mixture of kinesin and dynein. The 
distributions of distances travelled differ significantly (p = 7.4 x 10-5) as verified by a 
Kolmogorov–Smirnov test. The distributions of distances travelled by 80% phosphorylated and 
unphosphorylated beads also differed significantly (p = 4.7 x 10-5)  
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MIXTURE OF 
MOTORS 
NUMBER OF 
OBSERVATIONS 
MEAN 
DISTANCE 
STANDARD 
DEVIATION 
OF 
DISTANCES 
MEAN 
VELOCITY 
STANDARD 
DEVIATION 
OF 
VELOCITIES 
S175A + 
Dynein 
74 1.7 µm 3.8 µm 23.5 nm/s 145.9 nm/s 
S175D + 
Dynein 
151 0.4 µm 4.3 µm -55.6 nm/s 127.4 nm/s 
Unphosphorylat
ed kinesin + 
Dynein 
105 3.4 µm 4.0 µm 169.8 nm/s 251.1 nm/s 
80% 
phosphorylated 
kinesin+ 
Dynein 
117 0.6 µm 4.4 µm 51.7 nm/s 210.9 nm/s!
Table 3.3: Motility assay data for mutated and phosphorylated kinesin. 
!
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Figure 3.11: A. Distances traveled by beads coated with kinesin-888 and dynein. B. Velocities of kinesin-888 and 
dynein coated beads. C. Distances traveled by full-length kinesin and dynein coated beads. D. Velocities of full-length 
kinesin and dynein coated beads. Positive distances indicate net motion toward the microtubule plus end and 
negative distances and velocities indicate motion toward the minus end.  
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Chapter 4: Conclusions 
4.1: Effects of Serine 175 Phosphorylation 
We used biochemical and biophysical assays to probe the effect of serine 175 phosphorylation 
on the behavior of the kinesin motor protein.  Our goal was to discover the mechanism by which 
this phosphorylation site affected kinesin-based microtubule transport. In three biochemical 
assays, we found no change. First, in we found that a phosphomimetic kinesin did not possess 
an altered ATPase activity or Michaelis-Menten constant, indicating that addition of a negative 
charge at S175 did not affect the ability of kinesin to bind and hydrolyze ATP. Second, we have 
shown that enzyme kinetic parameters are unchanged in phosphomimetic kinesin when 
microtubule affinity was tested. Third, the processivity of phosphomimetic and non-
phosphorylatable kinesin did not significantly differ. In summary there is no observable 
difference in the biochemical properties of unphosphorylated and phosphomimetic kinesin. 
However, we did see a difference in a two-motor motility assay and in a stall force 
measurement. Phosphorylated kinesin had a lower stall force than unphosphorylated kinesin. 
With a lower stall force the ability of phosphorylated kinesin to pull against a load is diminished. 
We also found that when both kinesin and dynein were attached to a polystyrene bead cargo, 
more motion toward the microtubule minus end was observed if phosphorylated or 
phosphomimetic kinesin was used than if unmodified kinesin was used. These results clearly 
demonstrate that the mechanical properties of kinesin are attenuated by S175 phosphorylation. 
 
4.2: An Applied Force Leads to Defects in Kinesin Transport  
We propose that the attenuation of kinesin from S175 phosphorylation is evident only upon the 
application of an external force. Two pieces of evidence support this. First, we observe an 
attenuated stall force that is 0.9 pN less than the stall force in the absence of phosphorylation 
for full-length protein and 2 pN less in the case of a phosphomimetic construct. Second, in two-
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motor transport a recent study suggests that dynein remains bound to the microtubule during 
plus-end transport, dragging behind kinesin (1). This dragging acts as an opposing force that 
kinesin must work against. The ability of kinesin to pull against a force is reduced by 
phosphorylation of S175. A phosphorylated kinesin with a decreased stall force likely cannot pull 
against a few dynein as effectively as unphosphorylated kinesin. It would therefore lose the “tug-
of-war”, thus shifting the balance toward more minus-end directed transport. The conclusion that 
dynein stays attached to the microtubule during plus-end directed movement is further 
supported by Tonks-Hoffman observed that in optical trapping experiments, dynein would 
remain attached to microtubules and take backward steps under an opposing force (2). The 
model of transport proposed by Blehm et al. and Tonks-Hoffman et al. is known as the 
“synergistic model” in which kinesin detaches from the microtubule during dynein-driven, minus-
end transport, but dynein stays attached during kinesin-driven, plus-end transport (Fig 4.1). !
!
Figure 4.1: The Synergistic model of microtubule transport. During minus-end transport, dynein carries the cargo, but 
kinesin detaches. During plus-end transport, dynein drags behind kinesin.  
Based on the synergistic model, it is likely that the reduction in plus-end motion we observe in 
phosphorylated kinesin and dynein coated beads is force-mediated. The opposing force 
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generated by dynein during plus-end directed transport shifts the balance between the two 
motors to favor minus-end transport as our data demonstrates.  
 
4.3: Addition of a Negative Charge at Serine 175 is Sufficient for Kinesin 
Attenuation  
Our experiments were performed in an in vitro system. The lack of external signaling molecules 
that would be present in a cell or cytoplasm allows us to isolate the effect of JNK3 
phosphorylation on kinesin. Previous experiments by Morfini et al. linked JNK3 to transport 
defects in neurons and in squid axoplasm. The latter contains all of the signaling molecules that 
would be present in a cell and make it difficult to directly link JNK3 phosphorylation alone to 
transport defects in kinesin (3, 4). Our results indicate that phosphorylation alone is sufficient to 
decrease the stall-force of kinesin and bias the movement of cargo towards the minus end of 
microtubules when dynein is present. No other signaling or coordination molecules are needed.  
 
4.4: S175 Phosphorylation is Consistent with Axonal Transport Associated with 
Huntington’s Disease Pathology 
Our results show that phosphorylation of serine 175 in kinesin-1B by JNK-3 leads to a 
statistically significant bias in a cargo driven by both kinesin and dynein. As such, it may offer 
neurons the ability to direct traffic in the axon by attenuating plus-end directed microtubule 
traffic.  If constitutively upregulated in a pathological state, as may occur in Huntington’s disease 
or SBMA, serine 175 phosphorylation of kinesin could result in long-term inhibition of kinesin-
mediated axonal transport. Such transport defects my result in signaling defects and contribute 
to eventual neuronal death. Our results are consistent with the JNK3 mediated inhibition of fast 
axonal transport in squid axoplasm observed by Morfini et al (3, 4).  
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Chapter 5: Future Experiments 
5.1: Sedimentation Analysis 
When autoinhibited, kinesin folds into a compact conformation, where the cargo-binding domain 
docks near the motor domains (1). Interactions between positively charged amino acids in the 
cargo-binding domain and the negatively charged phosphate group at S175 could enhance 
autoinhibition. Enhanced autoinhibition inside of cells could interfere with cargo binding and 
contribute to diminished axonal transport.  
 
The relationship between phosphorylation and autoinhibition will be probed using a 
sedimentation analysis. Sedimentation is defined as the ratio of as the velocity to the 
acceleration of a particle due to centrifugation or another form of sedimentation.  
 
A sedimentation analysis in a centrifuge is a useful was to probe the hydrodynamic radius of 
biological molecules. In solution, the drag force on a particle in a centrifuge is given by Stokes’ 
law, 
, 
where Fd is the drag force, & is the viscosity, R is the radius of the particle and v is the velocity. 
The protein will reach a terminal velocity when the drag force is equal to the apparent centrifugal 
force,  
, 
where m is the mass of the protein, r is the distance between the protein and the center of the 
centrifuge and '2 is the angular acceleration of the centrifuge. Setting the drag force and 
centrifugal forces equal, allows for the computation of the sedimentation coefficient, s, according 
to 
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. 
 
Kinesin is known to undergo a transition to lower sedimentation coefficient at elevated salt 
concentrations. The addition of salt disrupts the docking of the auto inhibition domain to the 
motor domains and causes the protein to unfold into a spatially extended conformation, which 
has a larger hydrodynamic radius and hence a smaller sedimentation coefficient. By measuring 
the sedimentation coefficient of unphosphorylated kinesin and phosphorylated kinesin as a 
function of salt, changes in the efficiency of autoinhibition may be detectable. If phosphorylation 
enhanced autoinhibition, higher sedimentation values as a function of salt would be expected.  
 
To perform a sedimentation analysis on protein requires an analytical ultracentrifuge, capable of 
spinning at very high accelerations (a few hundred thousand g) and simultaneously monitoring 
the UV absorption within the sample. The sedimentation of the protein can be monitored by 
measuring the absorption of the protein, typically in the UV regime, as a function of time. 
 
5.2 Stall Force Experiments with Heterodimeric Kinesin !
Experiments on phosphorylated kinesin homo-dimers, which were 80% phosphorylated, 
described a very heterogeneous sample, essentially consisting of three different populations. If 
a heterodimeric kinesin allowing only for the phosphorylation of one single motor head were 
prepared, this would reduce the number of populations to only two.  
 
The stall force of 80% phosphorylated kinesin is 0.9 pN lower than the stall force of 
unphosphorylated protein. However, a 2 pN drop is observed for phosphomimetic kinesin-888 
compared with wild-type or non-phosphorylatable kinesin. A phosphate group adds a charge of  
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-2e and would be expected to have a larger effect than a phosphomimic, which adds a charge 
of -1e. However, it is possible that to have a decreased stall force requires that both motor 
domains be phosphorylated.  
 
To test the hypothesis that singly-phosphorylated kinesin do not have a decreased stall force, a 
heterodimeric kinesin in which only one motor domain can be phosphorylated could be used. 
Through using two different affinity purification steps, a kinesin in which one motor domain has 
an S175A mutation and the other is unmutated (residue 175 is the usual serine) could be 
created and later phosphorylated with JNK3.  
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Chapter 6: SHRImP Measurements of Ion Channels 
 
6.1: Biological Motivation 
The plasma membrane of a living cell is more than a static boundary that separates the cell 
from its environment. It is a highly dynamic structure that governs the interactions of a cell with 
the environment and other cells. Any signals from other cells or the environment that are 
destined for the cell interior must pass through the membrane. In animal cells, membrane 
proteins constitute approximately 30% of the cellular proteins and these proteins are the targets 
for approximately 40% of commercial pharmaceuticals (1). Knowledge of the structure and 
function of membrane proteins plays a crucial role in the development of new drugs (2, 3). 
Traditional structural studies of membrane proteins have relied on electron microscopy and x-
ray crystallography of purified proteins that have been extracted from cells. However, 
membrane proteins have been notoriously difficult to crystallize and crystallization can result in 
structures with artifacts. For this reason, it is desirable to develop methods that provide 
information about the structure of membrane proteins in the plasma membranes of cells, their 
most natural environment.  
 
Ion channels are a particularly interesting class of membrane proteins. These proteins allow 
cells to control the electric potential and propagation of electrical signals across their 
membranes. Ion channels can be divided into three groups according to the mechanism which 
triggers the opening and closing of the pore: mechanosensitive, voltage-gated, and ligand-
gated. Mechanosensitive ion channels open and close in response to pressure, shear force, or 
physical displacement. They act as sensors for hearing, touch, balance and osmoregulation. 
Voltage-gated ion channels respond to changes in the membrane potential of cells. These are 
responsible for the propagation of electric signals in neurons. Ligand-gated ion channels open 
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and close in response to the binding of small molecules and are prevalent in neuron to neuron 
and in neuron to muscle connections. 
 
Many ligand-gated ion channels are formed from several subunits, which can differ in identity. 
Knowing the possible combinations of subunits and their arrangement can offer insight into how 
the channels function as different subunits may impart different properties to the channel. For 
example, the AMPA (&-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) and NMDA (N-
methyl D-aspartate) receptors are two families of channels that are known to form from 
combinations of four subunits, but the geometry of the subunits is an open question. These 
channels are found in neurons in the central nervous system and play a crucial role in the 
formation of memories and learning (4, 5). The channels are always tetrameric, meaning they 
are formed from four different subunits. For both NMDA and AMPA receptors, only certain 
subunits combinations are possible.  
 
To illustrate how questions of subunit geometry can arise, the heterometic forms of the AMPA 
receptor can be considered. While homomeric AMPA receptors consisting of four identical 
subunits are possible, physiologically, most AMPA receptors are heteromers formed from 
different subunit types. In the hippocampus, the most common types are formed from two 
GluR1 subunits are two GluR2 subunits or two GluR2 and two GluR3 (5, 6). The extracellular 
domain of these subunits has a parallelogram-like shape with two fold symmetry which gives 
rise to four possible subunit geometries for these receptors as illustrated in figure 6.1 
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Figure 6.1: Possible heterometic geometries for the extracellular domain of the AMPA receptor.  
 
6.2: SHRImP Fluorescence Experiments 
In our experiments, we attempted to apply fluorescence imaging to measure subunit 
geometries. The Single-molecule High Resolution Imaging with Photobleaching (SHRImP) 
technique was used (7). The SHRImP approach involves attaching fluorescent labels of the 
same dye to two of the receptor subunits at a time. After the first label photobleaches, the center 
of the point-spread function (PSF) of the remaining label can be located with nanometer 
accuracy using the FIONA technique, described previously. Subtracting the PSF of this dye 
from the images containing the fluorescence of two dyes allows us to also measure the position 
of the first label to photobleach with nanometer accuracy. From the positions of the two dyes, 
we can compute the distance between the fluorescent labels (Fig. 6.2). 
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Figure 6.2: Illustration of the SHRImP technique. The emission of two fluorophores, separated by less than the 
diffraction limit of light overlaps, making if difficult to measure the distance between then. However, after one of the 
fluorophore photobleaches, the FIONA technique can be applied to the remaining fluorophore to measure its position 
with high accuracy. The image of the remaining fluorophore is then subtracted from images containing both to 
construct an isolated image of the first fluorophore which can then be localized with FIONA.  
We chose to use SHRImP over fluorescence resonance energy transfer (FRET) or another 
distance measurement technique due to its range. SHRImP has been successfully applied to 
measure distances between 10 and 30 nm with nanometer precision, giving it a wide dynamic 
range (7). FRET functions by measuring the energy transfer from a “donor” fluorophore to an 
“acceptor” fluorophore. For FRET, the energy transfer efficiency is related to the separation of 
the fluorophores, r, by 
. 
In contrast to SHRImP, which has a broad dynamic range, the dynamic range of FRET is much 
smaller due to the dependence of the FRET signal on the inverse sixth power of the dye-dye 
separation. FRET measurements are typically limited to within a few nanometers of R0, the 
Forster radius at which the energy transfer efficiency between two dyes is 50%.  Typical Forster 
radii are between 5 and 7nm, giving FRET a dynamic range of around 4 to 10 nm. For AMPA 
receptors, the relevant separations of the subunits are 9 nm, across the short diagonal of the 
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parallelogram and 12 nm across the longer diagonal. These distances are larger than the range 
in which FRET functions well but within the range where SHRImP works.  
 
6.3: Neuromuscular Junction Type Nicotinic Acetylcholine Receptor Test Case 
Neuromuscular nicotinic acetylcholine receptors (NMJ-nAChRs) have been extensively studied 
and crystallized with 0.4 nm resolution (8). They play a role in muscle contraction. Acetylcholine 
binds to these receptors and causes them to open. Sodium ions enter through an open channel 
and set off a cascade of cell signaling that results in muscle contraction. The well-established 
structure of NMJ-NAChRs makes them a good control case. These are heteropentameric 
receptors that contain two ( subunits, one ) subunit, one *, and either one $ or + subunit 
depending on whether the receptor is an adult form (+) or embryonic form ($) (Figure 6.3). To 
perform SHRImP distance measurements, fluorescently labeled &-bungarotoxin can be 
attached to the receptors. This toxin, from Bungarus multicinctus (snake), binds naturally with a 
very high affinity at the (/$ (or (/+) and (/* receptor interfaces as can be seen in figure 6.3 (9). 
Bungarotoxin is commercially available with single fluorescent labels. These labels are attached 
at lysine residues. Our task is to measure the separation between two fluorescent bungarotoxin. 
Depending on the lysine residue, there is a 7.6 to 10 nm separation of the dyes, with an 8.6 nm 
separation corresponding to the most probable labeling of solvent-exposed lysines.   
!
Figure 6.3: Side view (A) and top view (B) of the NMJ-nAChR. Bungarotoxin is shown in green. From PDB structures 
2BG9 and 2QC1. 
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6.4 Materials and Methods for NMJ-nAChR SHRImP 
6.4.1 Cell Culture 
HEK 293 cells (ATCC) were maintained in DMEM (Gibco) supplemented with 10% fetal bovine 
serum, 4mM L. glutamine, 25U/ml penicillin and 25mg/ml streptomycin. Cells were grown to 80-
90% confluency in 35mm glass-bottom dishes at 37C and 5% CO2. One day prior to 
transfection, the media in the dishes was exchanged for media with no antibiotics. To express 
the NMJ-NAChRs, cells were transiently transfected using lipofectamine with cDNA for the  &, ", 
', and % subunits (a gift from William Green's laboratory at the University of Chicago). 10 ul of 
lipofectamine and 1ug & cDNA, and 0.5ug each of  ", ', and % cDNA were added to the dishes 
16-20 hours prior to experiments.  
 
6.4.2 Receptor Labeling 
Cells were incubated for 30 minutes in a blocking solution of OptiMem containing 8mg/ml BSA 
and 4 mg/ml casein at 37 oC. We initially used Alexa 647 conjugated bungarotoxin (Invitrogen) 
to label the receptors but later switched to CF633 due to its enhanced photostability. The 
bungarotoxin-dye conjugates were added to the blocking solution to a final concentration of 150 
nM and cells were incubated in this solution for 30-45 minutes at 37C. To remove unbound 
bungarotoxin cells were washed 3 times in DBPS and then fixed for 30 minutes in a 4% 
paraformaldehyde solution in DPBS at room temperature. Following fixation, cells were washed 
2 times in DPBS and imaged in DBPS.  
 
6.4.3 Image Acquisition 
Total internal reflection imaging of cells was performed on an Olympus IX71 microscope using a 
100X 1.45 NA oil-immersion TIRF objective with a 633 nm excitation laser. A Semrock Brightline 
Di01-R635-25x36 dichroic mirror, a Semrock Brightline FF01-725/150-25 emission filter, and an 
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Andor iXon+ EMCCD camera were used to image the labeled receptors. Frame rates of 10-20 
Hz were used for image acquisition.  
 
6.4.4 Image Analysis 
Fluorescent spots were analyzed with an IDL SHRImP analysis code written by Matt Gordon 
that was edited to include background subtraction of cell autofluorescence (7). The inclusion of 
background subtraction in the SHRImP analysis was necessary to remove the autofluorescence 
of the cells. The autofluorescence of the cells photobleached on a longer time scale than the 
fluorescent dyes, making it possible to average 10 images after the photobleaching of both dyes 
attached after a receptor and subtract this to remove the autofluorescent background. The 
counting of photobleaching steps was initially performed “by eye” but later an automated step-
finding algorithm was implemented that employed a C++ hidden Markov model (HMM) program. 
To count the number of photobleaching steps in a fluorescent spot, the C++ code fit HMMs for 
1-5 photobleaching steps to the intensity vs. time trace and used the Bayesian information 
criteria to select the best fit. Only traces which showed two clear photobleaching steps, 
corresponding to two fluorescent dyes, were used in the SHRImP analysis. The HMM analysis 
was done in collaboration with Nir Friedman and Karin Dahmen. The HMM used was adapted 
from code originally written by McKinney (10). 
 
6.4.5 Data Fitting 
Although the cells were fixed, this did not eliminate all motion of the proteins in the membrane. 
Formaldehyde fixes cells by forming methylene bridges between nitrogen atoms, which results 
in the cross-linking of proteins but does not affect lipids or carbohydrates in the membrane. This 
does not completely stop motion at the nanometer scale in the cell membrane and the residual 
motion of the proteins complicates a SHRImP experiment since the receptors can undergo 
some motion in the membrane in the time between when the pre- and post-photobleaching 
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images occur. We found this error to be of the same magnitude as the distances we attempted 
to measure.  For this case, the distribution of distances had a non-Gaussian distribution.  
 
Since distance is always defined to be positive measurement errors that overestimate the 
distance will be more common than errors that underestimate the distance. The exact form of 
the distribution was initially derived by Churchman, et al (11). The Churchman derivation 
assumes that the measured position of a fluorophore has a probability density function that is a 
Gaussian centered at the true position of the fluorophore, 
. 
If the true separation of two fluorophores is , the probability density of measured 
separations, , is 
. 
Writing the probability density function in radial coordinates in two dimensions for imaging in a 
plane and integrating over the angular coordinate yields 
, 
where I0 is modified Bessel function of order zero. This distribution is right-shifted compared to a 
Gaussian distribution and the skew increases with the error, ,, in the localization of the each 
fluorophore.  
 
6.5: Results 
Figure 6.4 shows a typical image of a cell expressing CF633 labeled NMJ NAChRs and a 
characteristic intensity versus time photobleaching trace from a single fluorescent spot with and 
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without TIRF microscopy. The autofluorescence of the cell is significant and it can clearly be 
seen that TIRF is necessary to acquire clean images of the receptors in the membrane.  
!
Figure 6.4: HEK cell with fluorescently labeled NMJ-nAChR receptors illuminated (A) with epifluorescence and (B) 
with TIRF.  
The measured SHRImP distances are plotted in figure 6.5 along with a fit. The distances were 
fit to the non-Gaussian, Churchman distribution plus a constant to account for background due 
to two spots on separate receptors, 
.   
The addition of a constant background term to account for dyes that non-specifically stick to 
glass near each other was also found to be necessary in the original Gordon et al. study that 
established the SHRImP technique (7).  
! *'!
!
Figure 6.5: Distribution of measured dye separations on NMJ-nAChR using SHRImP. 
From the fit, we measured a true separation of µ = 13.8 ± 1.0 nm and a standard deviation of 
the location of individual fluorophores of , = 9.3 ± 1.0 nm.  
 
From the crystal structure of the NMJ-nAChR, we would have expected to measure a smaller 
separation.  Furthermore, from the photon counts of the individual dyes, we would expect a 
smaller error in fluorophore localization than the 9.3 nm fit to sigma. However, an examination of 
individual spots indicated that the receptors were not fixed at the nanometer scale, but rather 
most were motile within an area with a 10-50 nm radius on a timescale commensurate with our 
imaging rate of 10-100 Hz. We suspected that the chemical fixation was not sufficient to hold 
the receptors in place and this was corroborated by a previous study (12).  If the receptors could 
be better immobilized, errors in localization would diminish and we may be able to measure 
! *(!
more accurate distances.  
 
To test whether the motion we observed was due to the receptors but not drift of the microscope 
stage or camera, we examined different fluorescent spots from the same cell image. If drift were 
the underlying issue, we would expect the motion of the spots to be correlated. However, the 
spots appeared to move independently, suggesting that random motions within the cell 
membrane were to blame for the large localization errors (Figure 6.6).  
 
A 
variety of fixation techniques were explored, but none eliminated the receptor motion we 
observed in the membrane. We added 0.1% glutaraldehyde to the 4% formaldehyde mixture. 
Glutaraldehyde polymers are smaller than formaldehyde and a mixture of the two is commonly 
used to fix tissue for electron microscopy since glutaraldehyde and can penetrate samples 
faster and more effectively than formaldehyde alone. However, this did not alter the random 
motion of the receptors. We also tried a variety of mounting agents to see whether these would 
better immobilize receptors. These were thick fluids that harden and are typically used to 
preserve fluorescently stained cell samples for long-term storage. We experimented with mowiol 
(0.1 g/ml in 50 mM Tris with 25% glycerol, pH=8.3), Fluoromount G (Southern Biotech), and 
Prolong Gold (Invitrogen). These media all had higher indices of refraction than water, which 
made achieving total internal reflection at the glass-media interface impossible. Instead, total 
Figure 6.6: Position of two receptors in the same HEK cell as a function of time. The error bars represent the 
FIONA localization error in each frame. Both receptors move 10-20 nm/sec, but their motion is not 
coordinated.  
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internal reflection imaging in these media required the use of quartz cover slips and a 1.65 NA 
objective. The NA objective required the use of ventilation to remove the toxic fumes from the 
high-NA microscopy oil. The use of media did not offer an improvement in fixation and also 
suffered from the high cost of quartz cover slips and hassle of ventilation.  
 
Finally, we attempted to track the receptors and thus control their motion. The mAb35 antibody 
attaches to extracellular surface of the ( subunits of the receptors (13). It does not compete with 
bungarotoxin for binding which binds at the (/* and (/$ interfaces on the sides of the receptors. 
Our goal was to use fluorescent mAb35 to track receptors. It was not commercially available 
with fluorophores attached. We first attempted to use a fluorescent secondary antibody to 
mAb35. In these experiments, we first incubated cells in the presence of bungarotoxin with 
CF633 dye and unlabeled mab 35. We then added a secondary antibody labeled with R-PE (R-
Phycoerythrin), a fluorophore that is spectrally distinct from CF633. These experiments were not 
successful. We could track the CF633 bungarotoxin and antibodies simultaneously, but did not 
see coordinated motion. Figure 6.7 shows an example trace of the positions of the antibody and 
CF633 over time. The error bars represent the FIONA accuracy for each frame.  
! **!
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Figure 6.7: Dual-labeling of a single receptor. The green trace tracks the position of the R-PE labeled antibody as a 
function of time. The red trace is the position of the CF-633 labeled bungarotoxin. The error bars are the FIONA 
localization errors.  It does not appear that the motion of the antibody and bungarotoxin labels are coordinated.  
We suspected that the size of the R-PE secondary antibodies could be problematic. R-PE is a 
very large protein from the phycobiliprotein family and has a molecular weight of 240 kDA. 
Antibodies are 150kDa and 10-15 nm in size. The use of a secondary and a primary antibody to 
link R-PE to the channel created a very large antibody labeling complex, that was itself larger 
than then receptor protein. It is possible that this complex was flexible and the R-PE dye on the 
secondary antibody moved independently of the bungarotoxin-fluorophore attached to the 
receptor. If a fluorescent primary antibody were used instead, this would eliminate the need for 
a fluorescent secondary antibody and it is possible that a primary antibody alone would be less 
flexible. To test this, we attempted to label mAb35 directly with a fluorophore. We used an Alexa 
! "++!
555 antibody labeling kit (Invitrogen, A20187) but did not obtain good labeling.  
 
6.5 Conclusions 
While we were not able to resolve the issue of motion in the cell membrane that persisted after 
fixation to obtain a precise measurement of the distance across an NMJ-nAChR, our 
measurement of 14 nm for a true distance separation of ~8nm demonstrates that we are 
capable of measuring sub-diffraction limited distances associated with proteins in the cell 
membrane. With further improvement in fixation or tracking to correct for receptor motion, more 
accurate distances could be measured.  SHRImP could be used to answer questions about 
receptor subunit geometry by directly studying proteins in their native environment of the cell 
membrane. With improved fixation, SHRImP could be applied to the AMPA receptor to solve the 
puzzle of how its different subunits are arranged.      
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Appendix 
 
Glossary of Biological Terms 
!
&-bungarotoxin: A snake toxin that can be attached to a fluorescent dye and used to tightly bind 
the dye to proteins of interest.   
 
Anterograde: Motion away from the center of a cell toward the periphery.  
 
AMPA receptor: A type of ligand-gated ion channel in the nervous system involved in memory 
and learning.   
 
ATP (adenosine triphosphate): The “energy currency” currency of the cell. It provides energy 
that is crucial for many reactions inside cells.  
  
Axon: Long, narrow process that branches off a neuron cell body. Axons are responsible for 
transmitting chemical and electrical signals across synapses to neighboring neurons. Each 
neuron has one axon.  
 
Dendrites: Long, narrow processes that branch off a neuron cell body. They are responsible for 
receiving chemical and electrical signals across synapses sent by axons of neighboring 
neurons. A single neuron can have hundreds of dendrites.  
 
Dynein: A minus end directed microtubule motor.  
 
Eukaryote: An organism made up of cells with nuclei. 
  
FIONA (Fluorescent Imaging with One Nanometer Accuracy): A technique for localizing a 
fluorescent dye by fitting the emitted light to a 2-D Gaussian and finding the standard error of 
the mean.   
  
GluR1/2/3/4: AMPA receptor subunits.  
 
Isoform: One of a variety of forms of a protein that have only slight differences in sequence but 
share similar structures and functions.  
 
JNK3 (c-Jun N-terminal kinase 3): A stress-signaling kinase. It is capable of phosphorylating 
kinesin-1.  
  
Kinesin-1: A plus end directed microtubule motor.  
 
Ligand: A small molecule that, in the context of ion channels, binds to a channel to regulate its 
opening and closing.   
 
Kinase: An enzyme that is capable of phosphorylating other proteins.  
 
Neuron: Cells that are specialized in communicating information in animals. They can receive, 
process, and transmit chemical and electric signals.  
 
Microtubule: Part of the cytoskeleton, these make up “highways” within eukaryotic cells.  
! "+$!
 
Minus end: End of the microtubule with exposed alpha tubulin. In cells, minus ends tend to point 
toward the nucleus.  
 
Motor domain: The part of the kinesin protein that binds microtubules and hydrolyzes ATP.  
  
Neuromuscular junction (NMJ) nicotinic acetylcholine receptor nAChR: A ligand-gated ion 
channel that exists at the junction between central nervous system and muscle cells. It has two 
natural bungarotoxin binding sites.   
  
NMDA receptor: A type of ligand-gated ion channel in the nervous system involved in memory 
and learning.   
 
Phosphorylation: Attachment of a phosphate group (PO4) to a protein.  
 
Plus end: End of the microtubule with exposed beta tubulin. In cells, plus ends tend to point 
toward the periphery, away from the nucleus.  
 
Processivity: The ability of a motor protein such as kinesin or dynein to take multiple steps along 
a track before dissociating.  
 
Residue: An amino acid within a protein. Residues are numbered starting with “1” at the N-
terminus, which is the end of a protein with an exposed amino group.  
 
Retrograde: Motion toward the center (nucleus) of a cell.  
 
SHRImP (Single Molecule High-resolution IMaging with Photobleaching): A distance 
measurement technique that involves using two dyes of the same color. After one of the dyes 
photobleaches, the fluorescence of the remaining dye is subtracted from the fluorescence of the 
two dyes before the photobleach to reconstruct the first dye. Both dyes are localized with FIONA 
and the distance between them is measured.  
 
Stall force: The maximum force that a molecular motor can exert.  
 
Tubulin: The building blocks of microtubules. Tubulin protein comes in two forms, called alpha 
and beta tubulin.  
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